Technical Analysis of GSK PHARMA.

TECHNICAL ANALYSIS
TERM PAPER
ON
TECHNICAL ANALYSIS OF GLAXOSMITHKLINE PHARMA
Submitted To: Mr. Amarjit Saini Submitted By:

LOVELY PROFESSIONAL UNIVERSITY Page 1
TECHNICAL ANALYSIS
Ajay kumar
RS1902 B50
Reg.no.-10906664

TECHNICAL ANALYSIS
COMPANY PROFILE

TECHNICAL ANALYSIS
INTRODUCTION
GSK is one of the few pharmaceutical companies researching both medicines and vaccines for the World Health Organization’s three priority
diseases – HIV/AIDS, tuberculosis and malaria, and are very proud to have developed some of the leading global medicines in these fields.
Headquartered in the UK and with operations based in the US, GSK is one of the industry leaders, with an estimated seven per cent of the world's
pharmaceutical market.
But being a leader brings responsibility. This means that GSK care about the impact that it’s have on the people and places touched by our mission
to improve health around the world.
It also means that GSK must help developing countries where debilitating disease affects millions of people and access to life-changing medicines
and vaccines is a problem. To meet this challenge, we are committed to providing discount medicines where they are needed the most.
As a company with a firm foundation in science, GSK have a flair for research and a track record of turning that research into powerful,
marketable drugs. Every hour GSK spend more than US$562,000 to find new medicines.
GSK produce medicines that treat six major disease areas – asthma, virus control, infections, mental health, diabetes and digestive conditions.
In addition, GSK is a leader in the important area of vaccines and is developing new treatments for cancer.
GSK also market other products, many of which are among the market leaders:
• Over-the-counter (OTC) medicines including Gaviscon and Panadol

• Dental products such as Aquafresh and Macleans
• Smoking control products Nicorette/Niquitin
• Nutritional healthcare drinks such as Lucozade, Ribena and Horlicks.

TECHNICAL ANALYSIS

TECHNICAL ANALYSIS
GSK’S WORLDWIDE MAP

TECHNICAL ANALYSIS
GSK WORLDWIDE
EUROPE
United Kingdom Cyprus Iceland Netherlands Spain

Albania Czech Republic Ireland Norway Sweden
TECHNICAL ANALYSIS
Austria Denmark Italy Poland Switzerland

Armenia Estonia Kazakhstan Portugal Ukraine
Belarus Finland Latvia Romania
Belgium France Lithuania Russia
Bosnia Herzegovina Germany Macedonia Serbia
Bulgaria Greece Malta Slovakia
Croatia Hungary Moldova Slovenia
NORTH AMERICA
United States Canada Mexico
CENTRAL AND SOUTH AMERICA
Argentina Costa Rica Honduras Uruguay

Brazil Ecuador Nicaragua Venezuela
Chile El Salvador Panama
Colombia Guatemala Peru
CARIBBEAN
Dominican Republic Jamaica Trinidad
ASIA AND AUSTRALASIA
Australia Hong Kong New Zealand Uzbekistan Azerbaijan India Pakistan
Bangladesh Japan Sri Lanka China Korea Taiwan
SOUTHEAST ASIA
Cambodia Malaysia Philippines Thailand` Indonesia Myanmar Singapore
Vietnam
AFRICA
TECHNICAL ANALYSIS
Algeria Morocco South Africa Kenya Nigeria
INTRODUCTION OF THE COMPANY IN INDIA
Established in the year 1924 in India GlaxoSmithKline Pharmaceuticals Ltd. (GSK Rx India) is one of the oldest pharmaceuticals company and
employs over 3500 people. Globally, we are a USD 42 billion, leading, research-based healthcare and pharmaceutical company. In India, we are
one of the market leaders with a turnover of Rs. 1500 crore and a share of 6.9 per cent.
The GSK India product portfolio includes:-
• Prescription medicines
 anti-infective
 dermatology
 gynecology
 diabetes

TECHNICAL ANALYSIS
 cardiovascular disease
 respiratory diseases
• Vaccines
 Hepatitis A
 Hepatitis B
 Invasive disease caused by H
 Influenza
 Chickenpox
 Diphtheria
 Pertussis
 Tetanus and others.
GSK India is aligning itself with the parent company in areas such as clinical trials, clinical data management, global pack management, sourcing
raw material and support for business processes including analytics.
GSK’s best-in-class field force, backed by a nation-wide network of stockiest, ensures that the Company’s products are readily available across
the nation.
GSK has two manufacturing units in India, located at Nasik and Thane as well as a clinical development centre in Bangalore. The state of art plant
at Nasik makes formulations while bulk drugs are manufactured at Thane.
Being a leader brings responsibility towards the communities in which we operate. At GSK we have a Corporate Social Responsibility program
that works towards fulfilling basic healthcare, education and other developmental needs of 15 tribal villages near Nasik. We work with

TECHNICAL ANALYSIS
underprivileged children from the slums of Mumbai, taking care of their developmental and health
needs. GSK also runs an HIV/AIDS helpline - considered to be a pioneering effort in India that
supports those in distress and despair.
GSK is committed to developing new and effective healthcare solutions. The values on which the group
was founded have always inspired growth and will continue to do so in times to come.
HISTORY 0F THE COMPANY

GSK Company has a rich history that goes back to the early eighteenth century.
1700-1799
1715
Plough Court pharmacy, the forerunner of Allen and Hanburys Ltd, is established in London by Silvanus Bevan.
1800-1849
1830
John K Smith opens his first drugstore in Philadelphia. John's younger brother, George, joins him in 1841 to form John K Smith & Co.
1850-1899
TECHNICAL ANALYSIS
1859
Beecham opens the world's first factory to be built solely for making medicines at St Helens in England.
1865
Mahlon Kline joins Smith and Shoemaker - as John K Smith and Co had become - as a bookkeeper
1873
Joseph Nathan, who left the UK to seek new business opportunities 20 years before, establishes a general
trading company at Wellington in New Zealand - Joseph Nathan and Co - the foundation for the Glaxo company to
be formed later.
1880
Burroughs Well come & Company is established in London by American pharmacists Henry Well come and
Silas Burroughs, four years after Joseph Nathan opened a London office.
1884
Tabloid is registered as a Burroughs Well come and Company trademark to describe its compressed tablets.
1885
Thomas Beecham's company acquires headquarters on the corner of Silver Street and Water Street, St Helens, England. Two years later, the
company's new factory in St Helens becomes the first in the area to have electricity
1900-1949
1902
The Well come Tropical Research Laboratories open
1906
TECHNICAL ANALYSIS
Glaxo is registered by Joseph Nathan and Co as a trademark for dried milk. A Burroughs Well come subsidiary is created in New York.
1908
The Glaxo department of Joseph Nathan and Co opens in London and the first "baby book" is published.
1913
Production of Beecham's Pills laxative reaches one million a day.
1919
Alex C Maclean establishes MacLean’s Ltd, manufacturing own-name products for chemists. Mahlon Kline begins the novel practice of sending
pharmaceutical samples through the mail to doctors across the US.
1945
Beecham Group Ltd is established, replacing Beecham Pills Ltd and Beecham Estates Ltd - later known as Beecham Group plc - and incorporates
Beecham Research Laboratories.
1947
Glaxo Laboratories Ltd absorbs the Joseph Nathan company and becomes the parent company. Glaxo is listed on the London Stock Exchange.
New Beecham laboratories are established at Brockham Park in Surrey, England.
1950-1999
1958
Glaxo acquires Allen and Hanburys Ltd.
1959
The Wellcome Foundation acquires Cooper, McDougall and Robertson Ltd, an animal health company founded in 1843.

TECHNICAL ANALYSIS
1970
Burroughs Wellcome Inc moves its production facility from New York to Greenville, North Carolina.
1978
Through the acquisition of Meyer Laboratories Inc, Glaxo's business in the US is started, to become Glaxo Inc from 1980.
1981
The anti-ulcer treatment Zantac (ranitidine) is launched by Glaxo and is to become the world's top-selling medicine by 1986.
1988
SmithKline BioScience Laboratories acquires one of its largest competitors, International Clinical Laboratories, Inc, increasing the company's size
by half and establishing SmithKline BioScience Laboratories as the industry leader.
The Nobel Prize for medicine is awarded to George Hitchings and Gertrude Elion, of Burroughs Wellcome Inc, and to Sir James Black, who had
worked at the Wellcome Foundation and Smith Kline and French Laboratories, "for their discoveries of important principles for drug treatment."
1998
SmithKline Beecham and the World Health Organization announce a collaboration to eliminate lymphatic filariasis (elephantiasis) by the year
2020. The largest pharmaceutical company in Poland is created with the acquisition of Polfa Poznan by Glaxo Well come.
2000-2001
GlaxoSmithKline formed through the merger of Glaxo Well come and SmithKline Beecham.
DEVELOPMENT OF THE COMPANY

TECHNICAL ANALYSIS
GlaxoSmithKline plc is a public limited company incorporated on 6th December 1999 under English law. Its shares are listed on the London
Stock Exchange and the New York Stock Exchange. On 27th December 2000 the company acquired Glaxo Wellcome plc and SmithKline
Beecham plc, both English public limited companies, by way of a scheme of arrangement for the merger of the two companies. Both Glaxo Well
come and SmithKline Beecham were major global healthcare businesses.
GSK plc and its subsidiary and associated undertakings constitute a major global healthcare group
engaged in the creation, discovery, development, manufacture and marketing of
pharmaceutical and consumer health-related products.
GSK has its corporate head office in London. It also has operational headquarters in Philadelphia
and Research Triangle Park, USA, and operations in some 114 countries, with products sold in over 140
countries. The principal research and development (R&D) facilities are in the UK, the USA, Belgium,
Italy, Japan and Spain. Products are currently manufactured in some 38 countries. The major markets for the Group’s products are the USA,
France, Japan, the UK, Italy, Germany and Spain.
ORGANIZATION AWARDS
• Business in the community award
• Awards for diversity and our community work.
• Corporate equality, US Human Rights Campaign Foundation
• Best diversity company
• Diversity and equal treatment
• Business champion
• Energy management through resilience and mental wellbeing
• Most socially responsible company
TECHNICAL ANALYSIS
• Most family friendly company

• Achieving significant milestones in leadership initiative
• Global Super Achiever award
• Excellence Through People standard
• Supporting the local community
• World-class health and safety excellence awards.
• Gold H.E.A.L.T.H award
• CEO cancer gold standard
• Best employers for healthy lifestyle gold award
• Unique workplace ergonomics
• Helping employees recognize health and performance links
• Awards for excellence 2007
PRODUCTS OF THE COMPANY
MEDICINES
• VACCINES
• CONSUMER HEALTHCARE BRANDS
.

TECHNICAL ANALYSIS
COMPETITOR’s CHART

TECHNICAL ANALYSIS
ORGANIZATION STRUCTURE
(HIERARCHY)

TECHNICAL ANALYSIS
ORGANIZATION MANAGEMENT
GSK Company is managed by the Board of Directors and the Corporate Executive Team.
The Board is comprised of five executive and 11 non-executive directors who are responsible for our corporate governance and ultimately
accountable for our activities, strategy and performance.
The Chief Executive Officer (CEO) is responsible for the management of the business and is assisted by the Corporate Executive Team that
manages our activities. Each member is responsible for a specific part of the business.
BOARDS OF DIRECTORS
The Board of Directors is responsible for GSK Company's corporate governance and ultimately accountable for our activities, strategy and
performance.
NAME OF BOARD OF DIRECTORS

Sir Christopher Gent - Non-Executive Chairman
Andrew Witty - Chief Executive Officer
Professor Sir Roy Anderson - Non-Executive Director
Dr Stephanie Burns - Non-Executive Director
Lawrence Culp - Non-Executive Director
Sir Crispin Davis - Non-Executive Director
Julian Heslop - Chief Financial Officer
Sir Deryck Maughan - Non-Executive Director
Dr Daniel Podolsky - Non-Executive Director

TECHNICAL ANALYSIS
Sir Ian Prosser - Senior Independent Non-Executive Director
Dr Ronaldo Schmitz - Non-Executive Director
Moncef Slaoui - Chairman, Research & Development
Tom de Swaan - Non-Executive Director
Chris Viehbacher - President, North American Pharmaceuticals
Sir Robert Wilson - Non-Executive Director
CORPORATE EXECUTIVE TEAM

The Chief Executive Officer is responsible for the management of the business and is assisted by the Corporate Executive Team.
Andrew Witty - Chief Executive Officer
Simon Bicknell - Senior Vice President, Company Secretary & Compliance Officer
John Clarke - President, Consumer Healthcare
Marc Dunoyer - President, Asia Pacific/Japan
Eddie Gray - President, Pharmaceuticals Europe
Julian Heslop - Chief Financial Officer
Abbas Hussain - President, Emerging Markets
Duncan Learmouth - Senior Vice President, Corporate Communications and Community Partnerships
Bill Louv - Chief Information Officer
Dan Phelan - Chief of Staff

TECHNICAL ANALYSIS
David Pulman - President, Global Manufacturing and Supply
David Redfern - Chief Strategy Officer
Moncef Slaoui - Chairman, Research & Development
Jean Stéphenne - President and General Manager, Biological
Claire Thomas - Senior Vice President, Human Resources
Chris Viehbacher - President, North American Pharmaceuticals
Bob Ingram - Vice Chairman, Pharmaceuticals
ORGANIZATION
STRUCTURE
GSK’S
MANAGEMENT
IN INDIA
BOARD OF DIRECTORS
D.S. Parekh - Chairman & Independent Director
V. Thyagarajan - Vice-Chairman & Non - Executive Director

TECHNICAL ANALYSIS
Dr. H. B. Joshipura - Managing Director
P. Bains - Non-Executive Director
R. R. Bajaaj - Independent Director
Dr. A. Banerjee - Executive Director - Technical
M.B. Kapadia - Senior Executive Director
N. Kaviratne - Independent Director
P.V. Nayak - Independent Director
V. Narayanan - Independent Director
Dr. M. Reilly - Non-Executive Director
R. Sequeira - Executive Director - Human Resources
MANAGEMENT TEAM
Dr. H. B. Joshipura - Chairman
M.B. Kapadia - Senior Executive Director
Dr. A. Banerjee - Executive Director - Technical
R. Sequeira - Executive Director - Human Resources
H. Singh - E.V. P - Pharmaceuticals
M. K. Vasanth Kumar - E.V.P. - Information Technology & Supply Chain
Dr. S. Joglekar - V.P. - Medical & Clinical Research
S. Khanna - V.P. - Finance
R. Limaye - V.P. - Marketing & Commercial Strategy
TECHNICAL ANALYSIS
S. Patel - V.P. - Legal & Corporate Affairs

S. Rajan - General Manager - Corporate Communications
WORLD TOPS PHARMACEUTICAL COMPANIES
RANKING CORPORATION MARKET SHARE

1 Pfizer 7.5%
2 GSK Parma 6.9%
3 Merck’s Pharmaceutical 5.1%
4 AstraZeneca 4.4%
5 BMS 4.1%
6 Novartis 3.9%
7 Johnson 3.8%
DIFFERENT TYPE OF ANALYSIS
• Technical Analysis
• Fundamental Analysis
TECHNICAL ANALYSIS
Technical Analysis operates on the theory that market prices at any given point in time reflect all known factors affecting supply and demand for
a particular market. Consequently, technical analysis focuses, not on evaluating those factors directly, but on an analysis of market prices
themselves. This approach theorize that a detailed analysis of, among other things, actual daily, weekly and monthly price fluctuations is the most
effective means of attempting to capitalize on the future course of price movements. Technical strategies generally utilize a series of mathematical

TECHNICAL ANALYSIS
measurements and calculations designed to monitor market activity. Trading decisions are based on signals generated by charts, manual
calculations, computers or their combinations.
Fundamental Analysis is based on the study of factors external to the trading markets which affect the supply and demand of a particular
market. It is in stark contrast to technical analysis since it focuses, not on price but on factors like weather, government policies, domestic and
foreign political and economic events and changing trade prospects.
Fundamental analysis theorizes that by monitoring relevant supply and demand factors for a particular market, a state of current or potential
disequilibrium of market conditions may be identified before the state has been reflected in the price level of that market.
Fundamental analysis assumes that markets are imperfect, that information is not instantaneously assimilated or disseminated and that
econometric models can be constructed to generate equilibrium prices, which may indicate that current prices are inconsistent with underlying
economic conditions, and will, accordingly, change in the future.
laxoSmithKline Pharmaceutical Ltd.

Historic Data since 01 Oct 2008 - 31 Sep 2010
Moving Average Oscellators RSI

10 20 30
Daily Days Days Days Basis Gai
Open Rate of Loss
Date High Low Averag Moving Moving Moving of 20th ns No.
Value change (L)
Close e value averag averag averag days (G) Run of
Value e e e Test Run
TECHNICAL ANALYSIS
1-Oct- 1188.7
1181.88
08 1175 1194 1173.15 5
3-Oct- 1177.8
1176.93
08 1176 1183.85 1175 5 -4.95 - 1
6-Oct-
1157.5
08 1160 1170 1146.25 1155 -19.43 -
7-Oct- 1150.7
1147.88
08 1145 1160 1060 5 -9.625 -
8-Oct-
1077.75
08 1063.8 1160 1040 1091.7 -70.13 -
10- 1069.1
1067.08
Oct-08 1065 1082.9 1050 5 -10.68 -
13- 1085.0
1072.53
Oct-08 1060 1095 1060 5 5.45 + 2
14- 1133.3
1116.68
Oct-08 1100 1145 1082.5 5 44.1 +
15- 1110.6
1122.83
Oct-08 5 1144.25 1101 1135 6.15 +
16-
1082.25
Oct-08 1060.1 1114 1060.1 1104.4 1120.33 -40.58 - 3
17-
1108.8
Oct-08 1128.4 1128.4 1080.15 1089.2 1113.02 26.6 + 4
20-
1095.95
Oct-08 1087 1113.9 1075 1104.9 1104.92 -12.85 - 5
21-
1099.15
Oct-08 1083 1120 1082 1115.3 1099.09 3.2 + 6
22- 1097.5
1109.78
Oct-08 1122 1122 1095.25 5 1095.28 10.6 +
23-
1062.8
Oct-08 1085 1085.5 1025.1 1040.6 1093.78 -46.98 - 7
24-
1004.68
Oct-08 1029 1051 945 980.35 1087.54 -58.13 -
TECHNICAL ANALYSIS
27-
974.35
Oct-08 950.9 1014 930 997.8 1077.73 -30.33 -
28-
1006.35
Oct-08 1010 1037.45 990.1 1002.7 1066.69 32 + 8
29- 1006.4
998.725
Oct-08 991 1020.05 990 5 1054.28 -7.625 - 9
31- 1070.3 1181.8
1035.18
Oct-08 1000 1080 989 5 1049.58 1084.95 8 -0.1241 36.4 + 10
3-Nov- 1070.1 1176.9
1084.48
08 5 1104.8 1070.15 1098.8 1047.14 1080.08 3 -0.0786 49.3 +
4-Nov- 1157.5
1071.1
08 1071.4 1088 1070 1070.8 1044.66 1074.79 0 -0.0746 -13.38 - 11
5-Nov- 1147.8
1063.15
08 1098 1098 1025 1028.3 1041.06 1070.07 8 -0.0738 -7.95 -
6-Nov- 1033.1 1077.7
1026.58
08 1020 1040 1000.5 5 1032.74 1064.01 5 -0.0475 -36.58 -
7-Nov- 1067.0
1042.7
08 1021.7 1080 1020 1063.7 1030.73 1062.26 8 -0.0228 16.1 + 12
10- 1072.5 0.0008
1073.45
Nov-08 1074 1091 1060.25 1072.9 1037.61 1062.57 3 6 30.8 +
11- 1078.6 1116.6
1075.78
Nov-08 1072.9 1090 1065.55 5 1047.75 1062.74 8 -0.0366 2.33 +
12- 1122.8
1056
Nov-08 1051.5 1070 1051 1060.5 1052.71 1059.7 3 -0.0595 -19.78 - 13
14- 1082.2
1065
Nov-08 1060 1075 1051.1 1070 1059.34 1056.81 5 -0.0159 9 + 14
17- 1064.8 1108.8
1079.93
Nov-08 1095 1095 1050 5 1063.82 1056.7 1077.91 0 -0.026 14.9 +
18- 1095.9
1071.75
Nov-08 1050 1109 1049.9 1093.5 1062.54 1054.84 1074.24 5 -0.0221 -8.175 - 15
19- 1099.1
1075.75
Nov-08 1070.4 1095 1070.4 1081.1 1063.01 1053.83 1070.86 5 -0.0213 4 + 16
20- 1075 1109 1061.15 1101 1088 1065.49 1053.28 1068.55 1109.7 -0.0196 12.3 +
TECHNICAL ANALYSIS
Nov-08 8
21- 1062.8 0.0423
1107.85
Nov-08 1090 1131 1081.25 1125.7 1073.62 1053.18 1067.21 0 9 19.8 +
24- 1113.2 1151.3 1004.6 0.1270
1132.3
Nov-08 5 1159.8 1113.25 5 1082.58 1056.65 1069.03 8 3 24.5 +
25- 1173.3 0.1953
1164.73 974.35
Nov-08 1156.1 1190 1156.1 5 1091.71 1064.66 1072.29 9 32.4 +
26- 1006.3 0.1533
1160.65
Nov-08 1171 1171 1122.35 1150.3 1100.2 1073.97 1075.22 5 3 -4.075 - 17
28- 1166.3 0.1346
1133.18 998.73
Nov-08 1100 1180 1100 5 1107.91 1080.31 1075.77 2 -27.48 -
1-Dec- 1154.6 1166.7 1035.1 0.1212
1160.7
08 5 1175 1154.65 5 1117.48 1088.41 1077.04 8 6 27.5 + 18
2-Dec- 1140.8 1084.4 0.0705
1161.03
08 5 1189.9 1100.05 1181.2 1125.59 1094.7 1079.66 8 9 0.33 +
3-Dec- 1071.1
1185.6
08 1181 1195 1170 1190.2 1136.98 1099.76 1082.22 0 0.1069 24.6 +
4-Dec- 1063.1 0.1145
1184.95
08 1190 1190 1168.5 1179.9 1147.9 1105.45 1085.19 5 7 -0.65 - 19
5-Dec- 1150.0 1026.5 0.1348
1165.03
08 1180 1180 1150 5 1155.6 1110.55 1087.38 8 7 -19.93 -
8-Dec- 1149.7 1042.7 0.1123
1159.83
08 1169.9 1170 1140.15 5 1160.8 1117.21 1089.05 0 3 -5.2 -
10- 1132.4 1073.4 0.0710
1149.73
Dec-08 1167 1167 1125.1 5 1162.54 1122.56 1091.95 5 6 -10.1 -
11- 1075.7 0.0561
1136.2
Dec-08 1121.1 1169.9 1121.1 1151.3 1159.69 1125.7 1096.33 8 7 -13.53 -
12- 1151.0 1135.5 1056.0 0.0826
1143.3
Dec-08 5 1154.95 1127 5 1157.95 1129.07 1101.97 0 7 7.1 + 20
15- 1065.0 0.0522
1120.6
Dec-08 1125 1145.3 1101 1116.2 1156.7 1132.3 1105.77 0 1 -22.7 - 21
16- 1079.9 0.0338
1116.45
Dec-08 1110 1134 1110 1122.9 1152.27 1134.88 1109.7 3 2 -4.15 -
TECHNICAL ANALYSIS
17- 1130.3 1071.7 0.0567

1132.58
Dec-08 1134.8 1139 1103 5 1149.43 1137.51 1112.94 5 5 16.1 + 22
18- 1075.7 0.0618
1142.25
Dec-08 1148.4 1148.4 1115.1 1136.1 1145.09 1141.03 1114.87 5 2 9.68 +
19- 1088.0
1125.1
Dec-08 1124.7 1145 1120 1125.5 1139.11 1143.5 1116.67 0 0.0341 -17.15 - 23
22- 1107.8 0.0136
1122.95
Dec-08 1129.8 1138 1112.3 1116.1 1134.9 1145.25 1118.66 5 3 -2.15 -
23- 1109.0 1132.3
1111.33
Dec-08 5 1124.9 1109.05 1113.6 1130.05 1145.42 1121.49 0 -0.0185 -11.63 -
24- 1164.7
1113.9
Dec-08 1110 1122.75 1107.1 1117.8 1126.47 1144.5 1123.86 3 -0.0436 2.58 + 24
26- 1126.0 1160.6
1126.93
Dec-08 1127.8 1129.7 1112.5 5 1125.54 1142.61 1125.64 5 -0.0291 13 +
29- 1133.1
1126.55
Dec-08 1112.5 1145 1110.2 1140.6 1123.86 1140.91 1127.34 8 -0.0058 -0.375 - 25
30- 1160.7
1142.5
Dec-08 1135 1155 1130 1150 1126.05 1141.37 1130.22 0 -0.0157 16 + 26
31- 1161.0
1158.5
Dec-08 1170 1170 1144 1147 1130.26 1141.26 1133.34 3 -0.0022 16 +
1-Jan- 1185.6
1138.8
09 1126.4 1159.95 1126.4 1151.2 1130.88 1140.15 1135.3 0 -0.0395 -19.7 - 27
2-Jan- 1147.3 1184.9
1146.18
09 1145 1155 1145 5 1131.27 1138.18 1137.78 5 -0.0327 7.37 + 28
5-Jan- 1165.0
1146
09 1146 1149 1137.05 1146 1133.36 1136.23 1140.12 3 -0.0163 -0.175 - 29
6-Jan- 1140.0 1145.2 1159.8
1142.65
09 5 1153 1140 5 1135.33 1135.12 1141.94 3 -0.0148 -3.35 -
7-Jan- 1149.9 1149.7
1136.13
09 5 1149.95 1113.15 1122.3 1137.81 1133.93 1142.89 3 -0.0118 -6.525 -
9-Jan- 1136.2
1125.4
09 1128.8 1140 1105 1122 1138.96 1132.71 1142.66 0 -0.0095 -10.72 -
12-Jan- 1111 1157.85 1105.15 1147.7 1129.38 1139.21 1132.37 1141.48 1143.3 -0.0122 3.97 + 30
TECHNICAL ANALYSIS
09 5 0
13-Jan- 1137.1 1120.6 0.0228
1146.23
09 5 1161 1135 1155.3 1141.18 1132.52 1141 0 7 16.8 +
14-Jan- 1116.4 0.0335
1153.95
09 1160 1160 1140 1147.9 1142.32 1134.19 1141.69 5 9 7.73 +
15-Jan- 1156.3 1132.5 0.0181
1153.18
09 1150 1162 1149.95 5 1141.79 1136.02 1141.44 8 9 -0.775 - 31
16-Jan- 1144.7 1167.0 1142.2 0.0119
1155.9
09 5 1175 1144.75 5 1143.5 1137.19 1141.27 5 5 2.73 + 32
19-Jan- 1163.3 1125.1 0.0332
1162.48
09 1161.6 1164.1 1155 5 1145.13 1138.2 1140.5 0 2 6.57 +
20-Jan- 1160.0 1122.9 0.0285
1155.03
09 1150 1164 1146.25 5 1146.03 1139.7 1139.5 5 6 -7.45 - 33
21-Jan- 1169.9 1111.3 0.0504
1167.38
09 1164.8 1176 1159.95 5 1148.5 1141.92 1139.58 3 4 12.3 + 34
22-Jan- 1113.9 0.0438
1162.75
09 1151 1182.1 1118.4 1174.5 1151.17 1144.49 1139.68 0 5 -4.625 - 35
23-Jan- 1173.6 1126.9 0.0365
1168.08
09 1162.5 1178 1160 5 1155.43 1147.2 1140.29 3 2 5.33 + 36
27-Jan- 1169.8 1126.5 0.0340
1164.93
09 1160 1177 1160 5 1158.99 1149.1 1141.24 5 6 -3.15 - 37
28-Jan- 1142.5
1170.15
09 1180 1180 1151 1160.3 1161.38 1151.28 1142.14 0 0.0242 5.23 + 38
29-Jan- 1148.5 1158.5 0.0019
1160.78
09 1173 1173 1140 5 1162.06 1152.19 1143.48 0 6 -9.375 - 39
30-Jan- 1138.8 0.0106
1150.9
09 1136 1171.9 1135 1165.8 1161.84 1151.81 1144.63 0 3 -9.875 -
2-Feb- 1157.4 1146.1 0.0071
1154.33
09 1151.2 1169 1151 5 1161.68 1152.59 1145.35 8 1 3.42 + 40
3-Feb- 1146.0
1151.85
09 1153.5 1159 1150 1150.2 1160.62 1152.87 1145.67 0 0.0051 -2.475 - 41
4-Feb- 1151.2 1142.6 0.0018
1144.73
09 5 1152.05 1135 1138.2 1159.59 1152.81 1146.33 5 2 -7.125 -
TECHNICAL ANALYSIS
5-Feb- 1136.1 0.0014

1137.75
09 1140 1145 1135 1135.5 1156.62 1152.56 1146.82 3 3 -6.975 -
6-Feb- 1154.4 1125.4 0.0223
1150.58
09 1146.7 1158 1133.1 5 1155.41 1153.29 1148.13 0 7 12.8 + 42
9-Feb- 1154.9 1129.3 0.0196
1151.53
09 5 1160 1140.5 1148.1 1153.75 1154.59 1149.38 8 1 0.95 +
10- 1140.6 1146.2 0.0031
1149.83
Feb-09 1159 1159 1135 5 1152.24 1155.61 1150.15 3 4 -1.7 - 43
11- 1144.9 1153.9
1150.68
Feb-09 5 1162 1144.95 1156.4 1150.29 1155.84 1150.95 5 -0.0028 0.85 + 44
12- 1158.8 1153.1 0.0083
1162.83
Feb-09 1166.8 1166.8 1154 5 1150.5 1156.28 1151.63 8 7 12.1 +
13- 1159.3 1155.9 0.0041
1160.68
Feb-09 1162 1168 1154.25 5 1151.48 1156.66 1151.7 0 3 -2.15 - 45
16- 1164.8 1162.4 0.0032
1166.23
Feb-09 5 1180 1161.6 1167.6 1152.67 1157.17 1152.61 8 3 5.55 + 46
17- 1155.0 0.0207
1178.95
Feb-09 1167.3 1198.5 1156.1 1190.6 1155.38 1158 1153.71 3 1 12.7 +
18- 1167.3 0.0261
1197.85
Feb-09 1199 1233.7 1189.95 1196.7 1160.69 1160.14 1155.43 8 1 18.9 +
19- 1162.7 0.0342
1202.55
Feb-09 1213.8 1214 1182.1 1191.3 1167.17 1161.9 1157.43 5 3 4.7 +
20- 1185.5 1168.0 0.0111
1181.08
Feb-09 5 1190 1171.2 1176.6 1170.22 1162.81 1158.93 8 3 -21.48 - 47
24- 1181.2 1164.9 0.0087
1175.13
Feb-09 1169 1200 1160 5 1172.58 1163.16 1160.59 3 6 -5.95 -
25- 1199.4 1182.0 1170.1
1190.75
Feb-09 5 1199.45 1180.1 5 1176.67 1164.46 1162.63 5 0.0176 15.6 + 48
26- 1177.5 1160.7 0.0155
1178.78
Feb-09 1180 1181 1172 5 1179.48 1164.89 1163.72 8 1 -11.97 - 49
27- 1199.9 1150.9 0.0317
1187.48
Feb-09 1175 1203.75 1175 5 1181.95 1166.22 1164.84 0 8 8.7 + 50

TECHNICAL ANALYSIS
3-Mar- 1191.0 1154.3 0.0278

1186.43
09 5 1214 1162.2 1181.8 1184.52 1168 1165.94 3 1 -1.05 - 51
4-Mar- 1151.8 0.0318
1188.55
09 1197 1197 1168 1180.1 1186.75 1169.71 1167.03 5 6 2.13 + 52
5-Mar- 1144.7 0.0381
1188.35
09 1190 1190 1170 1186.7 1187.69 1171.53 1167.89 3 1 -0.2 - 53
6-Mar- 1137.7 0.0474
1191.75
09 1184.4 1201.8 1173.7 1199.1 1187.08 1173.89 1169.12 5 6 3.4 + 54
9-Mar- 1150.5
1185.9
09 1182 1200 1182 1189.8 1185.42 1176.29 1169.74 8 0.0307 -5.85 - 55
12- 1151.5 0.0254
1180.85
Mar-09 1185 1185.15 1173.15 1176.7 1185.4 1177.81 1170.34 3 7 -5.05 -
13- 1149.8 0.0253
1178.95
Mar-09 1188 1188.8 1168 1169.9 1185.78 1179.18 1170.7 3 3 -1.9 -
16- 1150.6 0.0146
1167.55
Mar-09 1178.8 1178.8 1150 1156.3 1183.46 1180.06 1170.79 8 7 -11.4 -
17- 1155.8 1162.8
1157.88
Mar-09 1159.9 1163.8 1150.1 5 1181.37 1180.42 1170.38 3 -0.0043 -9.675 -
18- 1097.8 1160.6
1119.93
Mar-09 1142 1154.7 1080.15 5 1174.61 1178.28 1169.02 8 -0.0351 -37.95 -
19- 1101.8 1166.2
1105.93
Mar-09 1110 1120 1080.1 5 1166.56 1175.54 1167.52 3 -0.0517 -14 -
20- 1082.0 1178.9
1078.63
Mar-09 5 1099.9 1074 1075.2 1155.57 1171.16 1165 5 -0.0851 -27.3 -
23- 1041.8 1197.8
1058.43
Mar-09 1075 1086 1037.05 5 1142.58 1165.14 1161.88 5 -0.1164 -20.2 -
24- 1140.0 1045.3 1202.5
1092.7
Mar-09 5 1140.05 1035 5 1132.67 1159.88 1160.15 5 -0.0913 34.3 + 56
25- 1052.3 1181.0
1050.08
Mar-09 1047.8 1067.4 1036.5 5 1119.09 1152.25 1157.23 8 -0.1109 -42.63 - 57
26- 1175.1
1063.8
Mar-09 1063.9 1073.9 1053.05 1063.7 1107.39 1146.39 1154.33 3 -0.0947 13.7 + 58

TECHNICAL ANALYSIS
27- 1068.1 1190.7

1064.08
Mar-09 1060 1071.7 1060 5 1095.9 1140.84 1151.42 5 -0.1064 0.27 +
30- 1066.9 1076.4 1178.7
1071.7
Mar-09 5 1090 1064 5 1086.31 1134.89 1148.81 8 -0.0908 7.63 +
31- 1088.0 1187.4
1084.03
Mar-09 1080 1113 1073 5 1078.93 1130.15 1146.59 8 -0.0871 12.3 +
1-Apr- 1186.4
1089.1
09 1090 1095 1085 1088.2 1075.85 1125.23 1144.13 3 -0.082 5.07 +
2-Apr- 1087.7 1188.5
1084.38
09 1081 1097 1080 5 1073.69 1120.13 1141.59 5 -0.0876 -4.725 - 59
6-Apr- 1087.1 1085.7 1188.3
1086.45
09 5 1089 1080 5 1074.47 1115.02 1138.93 5 -0.0857 2.08 + 60
8-Apr- 1191.7
1082.1
09 1080 1089.5 1070 1084.2 1076.84 1109.71 1135.7 5 -0.092 -4.35 - 61
9-Apr- 1093.3 1185.9
1084.43
09 1075.5 1104.9 1065.65 5 1076.01 1104.34 1131.92 0 -0.0856 2.33 + 62
13- 1112.7 1180.8
1093.88
Apr-09 1075 1119.5 1075 5 1080.39 1099.74 1128.3 5 -0.0737 9.45 +
15- 1178.9
1092.5
Apr-09 1080 1111 1080 1105 1083.26 1095.32 1125.35 5 -0.0733 -1.375 - 63
16- 1114.9 1099.0 1167.5
1107
Apr-09 5 1114.95 1095 5 1087.56 1091.73 1123.08 5 -0.0519 14.5 + 64
17- 1157.8
1112.3
Apr-09 1108.8 1125 1097.45 1115.8 1091.62 1088.96 1120.46 8 -0.0394 5.3 +
20- 1119.9 0.0036
1124.05
Apr-09 1114.9 1138.7 1113.8 1133.2 1095.62 1087.27 1118.64 3 8 11.8 +
21- 1164.3 1105.9 0.0362
1145.98
Apr-09 1127.6 1174 1125 5 1101.31 1088.58 1117.25 3 1 21.9 +
22- 1078.6 0.0813
1166.4
Apr-09 1160 1180 1160 1172.8 1109.51 1091.6 1116.59 3 8 20.4 +
23- 1058.4 0.1089
1173.7
Apr-09 1172 1180 1165 1175.4 1118.23 1096.35 1116.09 3 1 7.3 +

TECHNICAL ANALYSIS
24- 1092.7 0.0687

1167.8
Apr-09 1167.5 1179.9 1167.15 1168.1 1126.8 1101.82 1115.41 0 3 -5.9 - 65
27- 1167.3 1050.0 0.1116
1167.33
Apr-09 1167.3 1185 1167 5 1135.09 1105.55 1114.59 8 6 -0.475 -
28- 1177.9 1063.8 0.1075
1178.23
Apr-09 5 1215 1168 1178.5 1143.53 1111.96 1114.34 0 6 10.9 + 66
29- 1173.9 1064.0 0.1014
1172.03
Apr-09 1170.1 1187.5 1167 5 1151.48 1117.37 1114.04 8 5 -6.2 - 67
4-May- 1169.7 1071.7 0.0855
1163.38
09 1157 1184.9 1157 5 1157.12 1122.34 1113.52 0 4 -8.65 -
5-May- 1084.0 0.0762
1166.7
09 1167.5 1173.05 1163.35 1165.9 1162.56 1127.09 1113.5 3 7 3.33 + 68
6-May- 1089.1 0.0723
1167.9
09 1172 1172 1160 1163.8 1166.94 1131.28 1113.83 0 5 1.2 +
7-May- 1084.3 0.0763
1167.15
09 1164.5 1172 1164.5 1169.8 1169.06 1135.18 1115.4 8 3 -0.75 - 69
8-May- 1086.4 0.0911
1185.45
09 1199 1251 1167.15 1171.9 1170.97 1140.24 1118.05 5 2 18.3 + 70
11-
1082.1
May- 1167.05
0
09 1168 1173 1165 1166.1 1170.3 1144.27 1121 0.0785 -18.4 - 71
12-
1084.4
May- 1165.2 1166.63
3
09 1168 1169 1161.6 5 1170.18 1148.49 1124.61 0.0758 -0.425 -
13-
1093.8
May- 1123 0.0266
8
09 1081.2 1170.6 1081.2 1164.8 1165.75 1150.42 1125.62 3 -43.63 -
14-
1092.5
May- 1169.4 1164.73 0.0661
0
09 1160 1177.2 1148 5 1164.4 1153.96 1129.44 1 41.7 + 72
15-
1107.0
May- 1179.8 0.0657
0
09 1189 1191 1165.65 1170.6 1165.18 1158.33 1133.31 6 15.1 +
TECHNICAL ANALYSIS
18-
1112.3
May- 1240 0.1148
0
09 1230 1250 1222 1250 1172.84 1164.98 1139.17 1 60.2 +
19-
1124.0
May- 1164.4
5
09 1210 1210.1 1092.3 1118.8 1172.61 1167.58 1142.26 0.0359 -75.6 - 73
20-
1145.9
May- 1141.1 1132.98
8
09 1124.8 1150 1121 5 1169.12 1168.03 1143.89 -0.0113 -31.43 -
21-
1166.4
May- 1092.3 1115.18
0
09 1138 1149.5 1070 5 1163.92 1166.49 1144.76 -0.0439 -17.8 -
22-
1173.7
May- 1101.6
0
09 1108.8 1108.8 1086 1094.4 1155.54 1163.25 1145.34 -0.0614 -13.58 -
25-
1167.8
May- 1108.45
0
09 1109 1116 1098 1107.9 1149.68 1159.99 1146.07 -0.0508 6.85 + 74
26-
1167.3
May- 1131.8
3
09 1129 1152 1125 1134.6 1146.19 1158.19 1147.73 -0.0304 23.3 +
27-
1178.2
May- 1142.6
3
09 1140 1155 1135 1145.2 1148.15 1156.95 1149.67 -0.0302 10.8 +
28-
1172.0
May- 1158.5
3
09 1160 1174 1141.15 1157 1147.53 1155.97 1151.82 -0.0115 15.9 +
29-
1163.3
May- 1164 0.0005
8
09 1164.7 1178 1157.05 1163.3 1145.95 1155.56 1154.2 4 5.5 +
1-Jun- 1166.7 0.0050
1172.6
09 1165 1193 1157 1180.2 1139.21 1156.03 1156.39 0 6 8.6 +

TECHNICAL ANALYSIS
2-Jun- 1167.9 0.0179

1188.9
09 1175.1 1208 1175.1 1202.7 1141.66 1157.14 1158.94 0 8 16.3 +
3-Jun- 1167.1 0.0321
1204.7
09 1208 1212 1200 1201.4 1148.83 1158.98 1161.63 5 7 15.8 +
4-Jun- 1209.9 1207.9 1185.4 0.0198
1208.95
09 5 1220 1200 5 1158.21 1161.07 1163.73 5 2 4.25 +
5-Jun- 1219.2 1167.0 0.0429
1217.13
09 1215 1250 1206.6 5 1169.76 1162.65 1165.42 5 1 8.17 +
8-Jun- 1166.6 0.0403
1213.75
09 1212.5 1230 1210 1215 1180.29 1164.98 1166.76 3 9 -3.375 - 75
9-Jun- 1210.1 1248.8 1123.0 0.0948
1229.5
09 5 1274 1210 5 1190.06 1168.13 1168.81 0 4 15.8 + 76
10-Jun- 1164.7 0.0825
1260.85
09 1254 1276 1250 1267.7 1201.89 1175.02 1171.93 3 3 31.3 +
11-Jun- 1179.8
1266.4
09 1262.1 1275 1254.25 1270.7 1212.68 1180.1 1174.87 0 0.0734 5.55 +
12-Jun- 1247.7 1240.0 0.0251
1271.23
09 1294.7 1294.7 1236 5 1223.4 1184.68 1178.18 0 8 4.82 +
15-Jun- 1252.1 1164.4 0.0954
1275.58
09 1299 1299 1230.2 5 1233.7 1186.45 1181.92 0 8 4.35 +
16-Jun- 1132.9 0.1153
1263.65
09 1277 1280 1231 1250.3 1241.17 1191.42 1185.15 8 4 -11.93 - 77
17-Jun- 1115.1 0.1208
1249.9
09 1240 1280 1235 1259.8 1245.69 1197.26 1187.88 8 1 -13.75 -
18-Jun- 1250.0 1101.6
1246.03
09 5 1259.95 1235 1242 1249.4 1203.81 1190.51 0 0.1311 -3.875 -
19-Jun- 1108.4 0.1027
1222.3
09 1235.8 1245 1190 1208.8 1249.92 1209.84 1191.74 5 1 -23.73 -
22-Jun- 1210.1 1131.8 0.0757
1217.58
09 1225 1230 1195 5 1250.3 1215.3 1193.42 0 9 -4.725 -
23-Jun- 1201.2 1206.6 1142.6 0.0536
1203.95
09 5 1225 1200 5 1247.75 1218.9 1194.67 0 9 -13.63 -

TECHNICAL ANALYSIS
24-Jun- 1224.6 1158.5 0.0477

1213.83
09 1203 1235 1197.45 5 1243.04 1222.47 1197.69 0 6 9.88 + 78
25-Jun- 1220.1 1221.2 1164.0 0.0487
1220.7
09 5 1239.7 1213 5 1238.47 1225.58 1199.56 0 1 6.88 +
26-Jun- 1172.6
1235.45
09 1238.8 1245 1212.1 1232.1 1234.9 1229.15 1201.42 0 0.0536 14.7 +
29-Jun- 1213.9 1188.9
1181.98
09 1150 1237.3 1150 5 1225.54 1229.62 1199.48 0 -0.0058 -53.47 - 79
30-Jun- 1204.7 0.0061
1212.1
09 1230 1230 1170 1194.2 1220.38 1230.78 1201.07 0 4 30.1 + 80
1-Jul- 1199.3 1217.9 1208.9
1208.65
09 5 1225 1195.05 5 1216.26 1230.97 1203.59 5 -0.0002 -3.45 - 81
2-Jul- 1217.1 0.0096
1228.9
09 1205 1270 1205 1252.8 1214.54 1231.97 1207.38 3 7 20.3 + 82
3-Jul- 1213.7 0.0430
1266.05
09 1260.1 1281 1257.2 1272 1218.92 1234.42 1212.87 5 9 37.1 +
6-Jul- 1275.0 1265.8 1229.5 0.0333
1270.45
09 5 1289 1255 5 1224.21 1237.25 1218.27 0 1 4.4 +
7-Jul- 1290.4 1260.8 0.0157
1280.73
09 1271 1300 1270 5 1231.88 1239.81 1223.23 5 6 10.3 +
8-Jul- 1266.4
1265.45
09 1270 1272.9 1253 1260.9 1237.05 1240.04 1227.33 0 -0.0008 -15.27 - 83
10-Jul- 1271.2
1253.2
09 1260.1 1264.95 1228.3 1246.3 1240.3 1239.38 1230.48 3 -0.0142 -12.25 -
13-Jul- 1228.5 1250.6 1275.5
1239.6
09 5 1262.8 1228.55 5 1240.71 1237.8 1233 8 -0.0282 -13.6 -
14-Jul- 1258.9 1277.4 1263.6
1268.2
09 5 1280 1251.1 5 1249.33 1237.43 1236.19 5 0.0036 28.6 + 84
15-Jul- 1249.9
1285.9
09 1279.9 1318.95 1272.3 1291.9 1256.71 1238.55 1239.42 0 0.0288 17.7 +
16-Jul- 1246.0
1299.35
09 1295 1309.95 1281 1303.7 1265.78 1241.02 1242.58 3 0.0428 13.4 +

TECHNICAL ANALYSIS
17-Jul- 1222.3 0.0603

1296.05
09 1303.7 1309.9 1270 1288.4 1272.5 1243.52 1245.48 0 4 -3.3 - 85
20-Jul- 1217.5 0.0588
1289.25
09 1288.4 1300 1284.05 1290.1 1274.82 1246.87 1247.88 8 7 -6.8 -
21-Jul- 1292.5 1203.9 0.0704
1288.78
09 1285 1296.45 1285 5 1276.65 1250.43 1250.39 5 6 -0.475 -
22-Jul- 1213.8 0.0694
1298.1
09 1290 1310 1290 1306.2 1278.39 1255.14 1252.67 3 3 9.32 + 86
23-Jul- 1335.7 1220.7
1322.88
09 1310 1340 1310 5 1284.13 1260.59 1254.74 0 0.0837 24.8 +
24-Jul- 1335.7 1328.0 1235.4 0.0780
1331.9
09 5 1350 1312.5 5 1292 1266.15 1256.92 5 7 9.03 +
27-Jul- 1347.3 1181.9 0.1406
1348.18
09 1349 1350 1268 5 1302.86 1271.78 1259.49 8 1 16.3 +
28-Jul- 1351.1 1212.1 0.1142
1350.58
09 1350 1355 1330.05 5 1311.1 1280.21 1261.99 0 4 2.4 +
29-Jul- 1208.6 0.1165
1349.5
09 1345 1361 1325 1354 1317.46 1287.08 1264.85 5 3 -1.075 - 87
30-Jul- 1352.1 1228.9 0.0994
1351.08
09 1350 1359.9 1350 5 1322.63 1294.21 1268.22 0 2 1.58 + 88
31-Jul- 1361.5 1266.0
1323.53
09 1285.5 1370 1285.5 5 1325.38 1298.94 1270.81 5 0.0454 -27.55 - 89
3-Aug- 1270.4 0.0725
1362.6
09 1340 1400.45 1330 1385.2 1332.71 1303.76 1275.48 5 3 39.1 + 90
4-Aug- 1387.1 1280.7 0.0861
1391.03
09 1394.9 1415 1380.4 5 1342.94 1309.79 1281.26 3 2 28.4 +
5-Aug- 1265.4 0.0862
1374.55
09 1376.1 1388 1350 1373 1350.58 1314.48 1286.95 5 1 -16.48 - 91
6-Aug- 1361.6 1253.2 0.0842
1358.83
09 1356 1384.8 1352 5 1354.18 1319.15 1291.78 0 8 -15.72 -
7-Aug- 1351.5 1239.6 0.0933
1355.28
09 1359 1360.05 1347 5 1356.51 1324.26 1296.27 0 2 -3.55 -

TECHNICAL ANALYSIS
10- 1268.2 0.0788

1368.25
Aug-09 1388 1388 1345.4 1348.5 1358.52 1330.69 1300.7 0 9 13 + 92
11- 1285.9 0.0816
1390.95
Aug-09 1424 1440 1309.05 1357.9 1362.56 1336.83 1307.66 0 9 22.7 +
12- 1299.3 0.0625
1380.65
Aug-09 1366.5 1411 1364.15 1394.8 1365.67 1341.56 1313.28 5 7 -10.3 - 93
13- 1431.2 1296.0 0.1015
1427.63
Aug-09 1424 1440.9 1403.05 5 1373.33 1347.98 1320.58 5 2 47 + 94
14- 1433.6 1289.2 0.1125
1434.33
Aug-09 1435 1455 1422 5 1384.41 1354.89 1327.43 5 3 6.7 +
17- 1422.5 1288.7 0.1028
1421.28
Aug-09 1420 1439.75 1415 5 1390.28 1361.49 1332.6 8 1 -13.05 - 95
18- 1298.1 0.1073
1437.5
Aug-09 1444 1444 1415.6 1431 1394.92 1368.93 1338.17 0 9 16.2 + 96
19- 1453.2 1322.8 0.0920
1444.63
Aug-09 1436 1460 1432 5 1401.93 1376.26 1343.63 8 3 7.13 +
20- 1448.0 1331.9 0.0918
1454.28
Aug-09 1460.5 1465 1440 5 1411.48 1382.83 1349.93 0 8 9.65 +
21- 1430.5 1348.1 0.0627
1432.78
Aug-09 1435 1443 1425.05 5 1419.23 1387.87 1355.91 8 5 -21.5 - 97
24- 1350.5 0.0558
1426
Aug-09 1430 1430 1413 1422 1425 1391.76 1362.13 8 5 -6.775 -
25- 1349.5 0.0445
1409.6
Aug-09 1410 1420 1392 1409.2 1426.87 1394.71 1366.84 0 4 -16.4 -
26- 1351.0 0.0411
1406.65
Aug-09 1401 1420 1401 1412.3 1429.47 1397.57 1370.86 8 3 -2.95 -
27- 1419.9 1401.3 1323.5 0.0658
1410.65
Aug-09 5 1419.95 1385 5 1427.77 1400.55 1374.57 3 3 4 + 98
28- 1424.5 1362.6 0.0335
1408.28
Aug-09 1392 1430 1390.05 5 1425.16 1404.79 1378.32 0 2 -2.375 - 99
31- 1391.0 0.0299
1432.65
Aug-09 1432 1460 1425.1 1433.3 1426.3 1408.29 1383.1 3 2 24.4 + 100

TECHNICAL ANALYSIS
1-Sep- 1374.5 0.0495

1442.6
09 1447.8 1454 1436 1437.4 1426.81 1410.87 1388.22 5 1 9.95 +
2-Sep- 1358.8 0.0605
1441.15
09 1441 1449.9 1431 1441.3 1426.46 1414.2 1392.99 3 9 -1.45 - 101
3-Sep- 1355.2 0.0752
1457.2
09 1460 1475 1421 1454.4 1426.76 1419.12 1397.47 8 1 16.1 + 102
4-Sep- 1368.2 0.0625
1453.85
09 1455 1475 1436 1452.7 1428.86 1424.04 1401.53 5 6 -3.35 - 103
7-Sep- 1461.6 1390.9 0.0545
1466.83
09 1472 1485 1446 5 1432.95 1428.97 1405.49 5 5 13 + 104
8-Sep- 1380.6
1457
09 1460 1460 1450 1454 1437.69 1432.28 1409.04 5 0.0553 -9.825 - 105
9-Sep- 1461.1 1427.6 0.0157
1450.08
09 5 1462 1435.6 1439 1442.03 1435.75 1412.39 3 3 -6.925 -
10- 1459.4 1434.3 0.0157
1456.98
Sep-09 1454.5 1495 1445 5 1446.66 1437.21 1415.92 3 9 6.9 + 106
11- 1437.7 1421.2 0.0209
1451.03
Sep-09 1464.3 1475 1425 5 1450.94 1438.05 1420.17 8 3 -5.95 - 107
14- 1437.5 0.0006
1438.4
Sep-09 1440 1442.9 1427.15 1436.8 1451.51 1438.91 1422.7 0 3 -12.63 -
15- 1444.6 0.0087
1457.25
Sep-09 1454.9 1465 1441.55 1459.6 1452.98 1439.89 1424.9 3 4 18.8 + 108
16- 1464.1 1454.2 0.0053
1462.08
Sep-09 1460 1473 1460 5 1455.07 1440.77 1427.82 8 6 4.83 +
17- 1432.7 0.0240
1467.25
Sep-09 1466 1475 1460.5 1468.5 1456.07 1441.41 1431.43 8 6 5.17 +
18- 1481.1 1426.0 0.0400
1483.08
Sep-09 1485 1498 1475 5 1459 1443.93 1435.69 0 2 15.8 +
24- 1409.6 0.0503
1480.55
Sep-09 1481 1496.7 1472.25 1480.1 1460.37 1446.66 1439.44 0 3 -2.525 - 109
25- 1406.6 0.0906
1534.15
Sep-09 1490 1601.9 1482 1578.3 1468.08 1452.88 1444.21 5 4 53.6 + 110

TECHNICAL ANALYSIS
29- 1410.6 0.1212

1581.7
Sep-09 1599 1619.65 1555 1564.4 1481.25 1461.64 1450.91 5 6 47.6 +
30- 1408.2 0.1108
1564.4
Sep-09 1572 1594 1543.1 1556.8 1491.99 1469.32 1455.47 8 6 -17.3 - 111
1-Oct- 1561.2 1432.6 0.0900
1561.63
09 1562 1575 1545 5 1503.05 1476.99 1459.72 5 3 -2.775 -
5-Oct- 1557.2 1442.6 0.0804
1558.63
09 1560 1585 1550.2 5 1515.07 1483.29 1464.29 0 3 -3 -
6-Oct- 1514.3 1441.1 0.0687
1540.18
09 1566 1566 1490 5 1523.36 1488.17 1467.72 5 1 -18.45 -
7-Oct- 1500.3 1457.2 0.0140
1477.68
09 1455 1555 1455 5 1524.92 1490 1468.82 0 5 -62.5 -
8-Oct- 1453.8 0.0305
1498.25
09 1504 1513 1425 1492.5 1528.02 1492.05 1470.28 5 4 20.6 + 112
9-Oct- 1519.2 1466.8 0.0291
1509.63
09 1500 1537.9 1481 5 1530.68 1494.84 1472.85 3 8 11.4 +
12- 1457.0 0.0493
1528.85
Oct-09 1534.9 1548.8 1519.3 1522.8 1535.51 1497.94 1476.27 0 1 19.2 +
14- 1562.8 1450.0 0.0647
1543.93
Oct-09 1525 1569 1525 5 1536.49 1502.28 1480.75 8 2 15.1 +
15- 1456.9 0.0723
1562.35
Oct-09 1570 1636 1550.1 1554.7 1534.55 1507.9 1485.94 8 2 18.4 +
16- 1601.4 1451.0 0.0873
1577.73
Oct-09 1554 1616 1550 5 1535.88 1513.94 1491.51 3 2 15.4 +
21- 1438.4 0.1156
1604.8
Oct-09 1609.9 1609.9 1598 1599.7 1540.2 1521.62 1498.06 0 8 27.1 +
22- 1602.0 1457.2 0.0986
1601.03
Oct-09 1600 1634.85 1590 5 1544.44 1529.76 1503.67 5 6 -3.775 - 113
23- 1462.0 0.1024
1611.9
Oct-09 1607 1624.9 1607 1616.8 1551.61 1537.49 1509.32 8 7 10.9 + 114
26- 1467.2 0.0770
1580.35
Oct-09 1555 1620 1535 1605.7 1561.88 1543.4 1513.96 5 8 -31.55 - 115

TECHNICAL ANALYSIS
27- 1483.0 0.0789

1600.2
Oct-09 1600 1606 1600 1600.4 1572.08 1550.05 1518.72 8 7 19.9 + 116
28- 1480.5 0.0854
1607.05
Oct-09 1602 1615.6 1600 1612.1 1581.82 1556.25 1523.83 5 4 6.85 +
29- 1600.0 1600.6 1534.1 0.0431
1600.35
Oct-09 5 1612 1600 5 1588.97 1562.24 1528.28 5 5 -6.7 - 117
30- 1581.7 0.0078
1594.15
Oct-09 1610 1615 1560 1578.3 1593.99 1565.24 1532.85 0 7 -6.2 -
6-Nov- 1559.1 1564.4 0.0049
1572.08
09 1585 1585 1551 5 1594.96 1564.76 1536.92 0 1 -22.08 -
9-Nov- 1561.6 0.0049
1569.4
09 1567.9 1596 1558 1570.9 1594.13 1565.01 1540.67 3 8 -2.675 -
10- 1558.6 0.0156
1583.05
Nov-09 1582 1593.5 1576.1 1584.1 1591.96 1566.08 1545.07 3 7 13.6 + 118
11- 1594.1 1540.1 0.0320
1589.58
Nov-09 1585 1599 1581.05 5 1590.81 1567.63 1550.11 8 7 6.53 +
12- 1477.6 0.0826
1599.8
Nov-09 1602 1602 1589 1597.6 1589.6 1570.61 1554.86 8 5 10.2 +
13- 1498.2 0.0777
1614.75
Nov-09 1592.2 1655 1592.2 1637.3 1593.04 1577.46 1559.95 5 6 15 +
16- 1665.1 1509.6 0.0946
1652.58
Nov-09 1640 1671 1638 5 1598.28 1585.18 1566.13 3 9 37.8 +
17- 1528.8 0.0907
1667.6
Nov-09 1670 1687 1655 1665.2 1604.33 1593.08 1572.28 5 5 15 +
18- 1543.9
1674.7
Nov-09 1666.5 1699 1665 1682.9 1611.77 1600.37 1578.75 3 0.0847 7.1 +
19- 1562.3
1687.65
Nov-09 1673 1715.9 1673 1702.3 1621.12 1607.55 1583.86 5 0.0802 13 +
20- 1676.8 1577.7 0.0711
1689.93
Nov-09 1703 1715.95 1661 5 1632.9 1613.93 1587.47 3 2 2.27 +
23- 1669.8 1604.8 0.0530
1689.93
Nov-09 1710 1710 1665 5 1644.96 1619.54 1591.66 0 4 0 +

TECHNICAL ANALYSIS
24- 1668.0 1658.5 1601.0

1663.3
Nov-09 5 1682.05 1652.35 5 1652.98 1622.47 1595.05 3 0.0389 -26.63 - 119
25- 1663.9 1611.9 0.0183
1641.53
Nov-09 5 1663.95 1610.15 1619.1 1658.18 1624.49 1597.81 0 8 -21.77 -
26- 1580.3 0.0313
1629.85
Nov-09 1625 1645 1606.05 1634.7 1661.18 1625.39 1600.8 5 2 -11.68 -
27- 1600.2 0.0229
1636.95
Nov-09 1640 1641 1601 1633.9 1663.4 1628.22 1606.11 0 7 7.1 + 120
30- 1670.7 1607.0 0.0278
1651.88
Nov-09 1633 1680 1620 5 1663.33 1630.8 1611.23 5 9 14.9 +
1-Dec- 1686.9 1600.3
1671.73
09 1656.5 1701.9 1656.5 5 1663.74 1634.04 1616.63 5 0.0446 19.8 +
2-Dec- 1594.1 0.0543
1680.75
09 1698 1698 1660.35 1663.5 1664.35 1638.06 1621.69 5 2 9.03 +
3-Dec- 1658.8 1572.0 0.0587
1664.43
09 1670 1690 1650 5 1662.03 1641.57 1625.71 8 4 -16.33 - 121
4-Dec- 1569.4 0.0561
1657.5
09 1642 1690 1642 1673 1658.78 1645.84 1628.88 0 4 -6.925 -
7-Dec- 1583.0 0.0602
1678.45
09 1680 1690 1666 1676.9 1657.64 1651.3 1632.24 5 6 21 + 122
8-Dec- 1589.5
1664.45
09 1661.8 1682.8 1658 1667.1 1657.75 1655.37 1634.23 8 0.0471 -14 - 123
9-Dec- 1649.5 1599.8 0.0374
1659.78
09 1670 1678.95 1640 5 1659.58 1658.88 1636.19 0 9 -4.675 -
10- 1614.7
1639.45
Dec-09 1645 1650 1627 1633.9 1660.54 1660.86 1637.11 5 0.0153 -20.33 -
11- 1652.5
1625.45
Dec-09 1635 1652.9 1607 1615.9 1659.39 1661.39 1638.61 8 -0.0164 -14 -
14- 1667.6
1605.7
Dec-09 1610 1620 1597 1601.4 1654.77 1659.05 1638.79 0 -0.0371 -19.75 -
15- 1603.6 1674.7
1606.33
Dec-09 1609 1627.9 1594 5 1648.23 1655.99 1638.77 0 -0.0408 0.63 + 124

TECHNICAL ANALYSIS
16- 1687.6
1595.6
Dec-09 1600 1609.8 1590 1591.2 1639.71 1652.03 1638.61 5 -0.0545 -10.73 - 125
17- 1689.9
1593.75
Dec-09 1608.9 1608.9 1575 1578.6 1632.65 1647.34 1638.6 3 -0.0569 -1.85 -
18- 1591.9 1689.9
1599.03
Dec-09 5 1645 1574 1606.1 1626.8 1642.79 1639.49 3 -0.0538 5.28 + 126
21- 1609.6 1663.3
1609.83
Dec-09 1610 1635 1590 5 1619.94 1638.79 1640.84 0 -0.0321 10.8 +
22- 1583.2 1641.5
1597.18
Dec-09 1611.1 1624.8 1578 5 1613.21 1635.48 1641.31 3 -0.027 -12.65 - 127
23- 1593.9 1629.8
1596.63
Dec-09 5 1613 1593.95 1599.3 1606.89 1633.23 1641.55 5 -0.0204 -0.55 -
24- 1636.9
1625.65
Dec-09 1605 1655 1591.25 1646.3 1605.51 1633.02 1642.41 5 -0.0069 29 + 128
29- 1594.0 1651.8
1624.28
Dec-09 1654.5 1655 1590 5 1605.4 1632.39 1642.73 8 -0.0167 -1.375 - 129
30- 1610.7 1671.7
1602.88
Dec-09 1595 1615 1585 5 1605.11 1629.94 1641.07 3 -0.0412 -21.4 -
31- 1610.0 1680.7
1612.53
Dec-09 1615 1617 1600 5 1605.73 1626.98 1639.23 5 -0.0406 9.65 + 130
4-Jan- 1602.0 1664.4
1611.93
10 5 1625 1602.05 1621.8 1607.37 1623.54 1637.14 3 -0.0315 -0.6 -
5-Jan- 1612.2 1617.1 1657.5
1614.7
10 5 1633 1612.15 5 1609.46 1621.05 1634.71 0 -0.0258 2.78 + 131
6-Jan- 1650.0 1639.3 1678.4
1644.7
10 5 1650.05 1612 5 1614.03 1620.41 1633.2 5 -0.0201 30 +
7-Jan- 1647.9 1664.4
1648.48
10 1649 1654.9 1639 5 1617.89 1618.91 1631.82 5 -0.0096 3.78 +
8-Jan- 1659.7
1635.45
10 1631 1650 1631 1639.9 1621.72 1617.46 1630.89 8 -0.0147 -13.02 - 132
11-Jan- 1626.6 1639.4 0.0270
1683.83
10 1741 1741 1615.5 5 1630.44 1618.67 1632.3 5 7 48.4 + 133

TECHNICAL ANALYSIS
12-Jan- 1638.9 1586.4 1625.4

1612.7
10 5 1638.95 1582.25 5 1629.15 1617.33 1631.73 5 -0.0078 -71.13 - 134
13-Jan- 1605.7
1580.6
10 1590 1610 1566 1571.2 1624.78 1615.09 1629.85 0 -0.0156 -32.1 -
14-Jan- 1560.1 1573.8 1606.3
1567
10 5 1599.8 1560.15 5 1621.19 1613.15 1627.02 3 -0.0245 -13.6 -
15-Jan- 1584.9 1595.6
1578.63
10 5 1585 1570 1572.3 1617.8 1611.77 1623.92 0 -0.0106 11.6 + 135
18-Jan- 1593.7
1567.15
10 1572 1575 1561.05 1562.3 1613.32 1610.34 1620.13 5 -0.0167 -11.47 - 136
19-Jan- 1557.6 1599.0
1570.08
10 1582.5 1582.5 1555 5 1608.86 1609.16 1616.99 3 -0.0181 2.92 + 137
20-Jan- 1558.6 1609.8
1561.83
10 1565 1581.3 1551 5 1600.57 1607.3 1613.8 3 -0.0298 -8.25 - 138
21-Jan- 1561.8 1597.1
1550.53
10 5 1561.85 1500 1539.2 1590.78 1604.34 1609.54 8 -0.0292 -11.3 -
22-Jan- 1512.6 1596.6
1511.33
10 1510 1533 1490.1 5 1578.37 1600.04 1604.43 3 -0.0534 -39.2 -
25-Jan- 1517.8 1625.6
1523.43
10 5 1535 1505 1529 1562.33 1596.38 1599.89 5 -0.0629 12.1 + 139
27-Jan- 1624.2
1522.6
10 1520 1544 1502.15 1525.2 1553.32 1591.23 1595.99 8 -0.0626 -0.825 - 140
28-Jan- 1533.0 1602.8
1538.53
10 1544 1545 1515 5 1549.11 1586.94 1593.09 8 -0.0401 15.9 + 141
29-Jan- 1520.1 1612.5
1529.08
10 1538 1538 1509.05 5 1545.32 1583.25 1590.54 3 -0.0518 -9.45 - 142
1-Feb- 1543.5 1611.9
1521.78
10 1500 1548 1500 5 1539.63 1578.72 1587.72 3 -0.0559 -7.3 -
2-Feb- 1554.9 1614.7
1546.18
10 5 1560 1536 1537.4 1537.53 1575.43 1586.07 0 -0.0424 24.4 + 143
3-Feb- 1644.7
1550.4
10 1540 1575 1535 1560.8 1535.57 1572.21 1584.63 0 -0.0573 4.22 +

TECHNICAL ANALYSIS
4-Feb- 1648.4
1565.9
10 1571.8 1571.8 1555.2 1560 1535.97 1568.27 1583.52 8 -0.0501 15.5 +
5-Feb- 1553.9 1635.4
1538.48
10 1523 1569.9 1510.55 5 1534.77 1562.77 1581.15 5 -0.0593 -27.43 - 144
8-Feb- 1683.8
1547.65
10 1569.8 1570 1509 1525.5 1538.4 1558.38 1579.5 3 -0.0809 9.18 + 145
9-Feb- 1612.7
1530.2
10 1530 1535 1511.05 1530.4 1539.08 1550.7 1577.28 0 -0.0512 -17.45 - 146
10- 1541.9 1580.6
1549.13
Feb-10 5 1565 1535.1 1556.3 1541.73 1547.52 1574.73 0 -0.0199 18.9 + 147
15- 1619.8 1576.8 1567.0 0.0200
1598.35
Feb-10 5 1619.85 1570 5 1547.71 1548.41 1573.87 0 1 49.2 +
16- 1578.6
1577.65
Feb-10 1590 1599.95 1551.15 1565.3 1552.57 1548.94 1573.03 3 -0.0006 -20.7 - 148
17- 1574.4 1580.3 1567.1 0.0065
1577.4
Feb-10 5 1585 1571.15 5 1558.13 1548.88 1571.85 5 4 -0.25 -
18- 1570.0
1581.85
Feb-10 1582 1590 1574 1581.7 1561.7 1549.62 1570.85 8 0.0075 4.45 + 149
19- 1649.6 1561.8 0.0332
1613.83
Feb-10 1578 1655 1578 5 1568.04 1551.8 1570.82 3 9 32 +
22- 1681.7 1550.5 0.0750
1666.88
Feb-10 1652 1684.95 1645 5 1578.14 1557.06 1571.56 3 4 53.1 +
23- 1511.3
1695.7
Feb-10 1686 1731 1662.15 1705.4 1593.86 1564.32 1573.14 3 0.122 28.8 +
24- 1523.4 0.1161
1700.35
Feb-10 1690 1719.9 1680.2 1710.7 1609.13 1573.77 1575.3 3 4 4.65 +
25- 1522.6
1711.25
Feb-10 1700 1730 1700 1722.5 1627.24 1583.16 1576.21 0 0.1239 10.9 +
26- 1538.5 0.1171
1718.75
Feb-10 1722 1722 1707 1715.5 1644.2 1592.97 1579.75 3 4 7.5 +
2-Mar- 1702.0 1529.0 0.1124
1701.03
10 1700 1719.9 1700 5 1654.47 1601.09 1583.76 8 5 -17.72 - 150

TECHNICAL ANALYSIS
3-Mar- 1521.7 0.1266

1714.5
10 1718 1719 1702 1711 1668.15 1610.36 1588.68 8 4 13.5 + 151
4-Mar- 1740.4 1546.1 0.1186
1729.63
10 1718.8 1785 1715 5 1683.38 1620.75 1593.71 8 5 15.1 +
5-Mar- 1550.4 0.1217
1739.15
10 1740.5 1768 1730 1737.8 1699.11 1630.4 1599.45 0 4 9.53 +
8-Mar- 1565.9 0.1239
1760.05
10 1750 1779.95 1750 1770.1 1713.73 1640.89 1605.78 0 9 20.9 +
9-Mar- 1750.5 1538.4 0.1443
1760.53
10 1770.5 1777.35 1737.95 5 1723.09 1650.62 1612.4 8 3 0.48 +
10- 1766.1 1547.6 0.1333
1754.08
Mar-10 1742 1770 1730.2 5 1728.93 1661.4 1619.19 5 8 -6.45 - 152
11- 1752.2 1744.9 1530.2 0.1427
1748.6
Mar-10 5 1770 1731.05 5 1733.76 1671.44 1627.1 0 3 -5.475 -
12- 1731.8 1549.1 0.1259
1744.18
Mar-10 1756.5 1769.85 1715.25 5 1737.05 1682.14 1634.45 3 1 -4.425 -
15- 1598.3 0.0764
1720.55
Mar-10 1743 1743 1696 1698.1 1737.23 1690.71 1641.05 5 5 -23.63 -
16- 1700.8 1577.6 0.0730
1692.93
Mar-10 1685 1713 1684 5 1736.42 1695.44 1646.2 5 7 -27.63 -
17- 1577.4 0.0593
1671.05
Mar-10 1650 1718.5 1650 1692.1 1732.07 1700.11 1650.93 0 7 -21.88 -
18- 1699.9 1703.0 1581.8 0.0756
1701.5
Mar-10 5 1710 1683 5 1729.26 1706.32 1656.92 5 4 30.5 + 153
19- 1725.0 1613.8 0.0627
1715.03
Mar-10 1705 1737.5 1705 5 1726.85 1712.98 1662.55 3 1 13.5 +
22- 1666.8 0.0368
1728.35
Mar-10 1720 1754.4 1720 1736.7 1723.68 1718.7 1668.48 8 8 13.3 +
23- 1745.9 1695.7 0.0252
1738.53
Mar-10 1731.1 1750 1731.1 5 1721.48 1722.29 1674.24 0 6 10.2 +
25- 1748.3 1700.3 0.0281
1748.18
Mar-10 1748 1755.5 1737.05 5 1720.89 1724.91 1681.23 5 3 9.65 +

TECHNICAL ANALYSIS
26- 1711.2
1709.5
Mar-10 1670 1755 1670 1749 1716.98 1725.37 1686.62 5 -0.001 -38.68 - 154
29- 1718.7 0.0185
1750.6
Mar-10 1745 1760 1745 1756.2 1717.62 1727.33 1693.97 5 3 41.1 +
30- 1774.9 1701.0 0.0390
1767.48
Mar-10 1760 1775 1750.05 5 1722.31 1729.77 1701.25 3 6 16.9 +
31- 1777.8 1714.5 0.0189
1746.93
Mar-10 1716 1780.5 1716 5 1727.71 1732.07 1706.2 0 1 -20.55 - 155
1-Apr- 1763.6 1729.6 0.0250
1772.88
10 1782.1 1784.9 1751.3 5 1737.9 1734.98 1712.71 3 1 26 + 156
5-Apr- 1784.9 1781.5 1739.1 0.0253
1783.25
10 5 1797 1751.1 5 1746.07 1737.67 1719.57 5 6 10.4 +
6-Apr- 1761.6 1760.0 0.0089
1775.83
10 1790 1790 1758 5 1752.15 1739.5 1726.03 5 6 -7.425 - 157
7-Apr- 1760.5
1760.5
10 1763 1782 1750 1758 1755.37 1739.52 1730.92 3 -1E-05 -15.33 -
8-Apr- 1754.0
1775.3
10 1785 1785 1752.3 1765.6 1759.04 1740.26 1734.54 8 0.0121 14.8 + 158
9-Apr- 1780.2 1748.6 0.0129
1771.23
10 1762.2 1782.95 1762.2 5 1761.35 1741.12 1737.06 0 4 -4.075 - 159
12- 1744.1 0.0214
1781.55
Apr-10 1775 1791 1770 1788.1 1768.55 1742.77 1739.76 8 3 10.3 + 160
13- 1720.5 0.0394
1788.5
Apr-10 1776.2 1806 1776.2 1800.8 1772.34 1744.98 1742.34 5 9 6.95 +
15- 1810.1 1692.9 0.0683
1808.58
Apr-10 1807 1824.75 1791 5 1776.45 1749.38 1745.33 3 1 20.1 +
16- 1671.0 0.0840
1811.55
Apr-10 1800 1850 1800 1823.1 1782.92 1755.31 1749.02 5 8 2.97 +
19- 1701.5 0.0755
1830.1
Apr-10 1812.5 1861 1812.05 1847.7 1788.64 1763.27 1752.87 0 8 18.6 +
20- 1856.1 1715.0 0.0799
1852.08
Apr-10 1848 1865 1847.3 5 1795.52 1770.8 1756.95 3 1 22 +

TECHNICAL ANALYSIS
21- 1864.9 1920.0 1728.3 0.0949

1892.5
Apr-10 5 1933 1851.4 5 1807.19 1779.67 1762.06 5 7 40.4 +
22- 1738.5 0.1010
1914.2
Apr-10 1925 1925 1890 1903.4 1822.56 1788.96 1767.2 3 5 21.7 +
23- 1897.2 1748.1
1918.63
Apr-10 1940 1940 1887 5 1836.89 1797.97 1772.47 8 0.0975 4.42 +
26- 1896.8 1709.5 0.1051
1889.33
Apr-10 5 1902.9 1873 1881.8 1848.7 1805.02 1776.98 0 9 -29.3 - 161
27- 1932.6 1750.6 0.0900
1908.28
Apr-10 5 1932.65 1880.05 1883.9 1861.37 1814.96 1782.3 0 7 19 + 162
28- 1898.6 1767.4 0.0717
1894.33
Apr-10 1890 1914.9 1875 5 1871.96 1822.15 1787.31 8 7 -13.95 - 163
29- 1746.9 0.0850
1895.55
Apr-10 1910 1918.95 1876.05 1881.1 1880.65 1828.55 1793.14 3 8 1.22 + 164
30- 1905.0 1772.8 0.0710
1898.78
Apr-10 1892.5 1915 1862 5 1889.38 1836.15 1800 8 1 3.23 +
3-May- 1898.3 1783.2 0.0622
1894.23
10 1890.1 1925 1818 5 1895.79 1842.21 1807.44 5 3 -4.55 - 165
4-May- 1775.8 0.0645
1890.5
10 1886.5 1907 1870 1894.5 1899.63 1847.58 1813.74 3 8 -3.725 -
5-May- 1760.5
1956.8
10 1971 1971 1897.45 1942.6 1906.06 1856.62 1821.8 0 0.1115 66.3 + 166
6-May- 1948.8 1982.1 1775.3 0.1071
1965.5
10 5 1991 1944.05 5 1911.19 1866.87 1829.7 0 4 8.7 +
7-May- 1771.2 0.1024
1952.65
10 1961 1974.95 1935.3 1944.3 1914.59 1875.74 1836.84 3 3 -12.85 - 167
10-
1781.5
May- 1989.2 1974.13 0.1080
5
10 1959 2013.7 1959 5 1923.07 1885.89 1844.37 9 21.5 + 168
11-
1788.5
May- 1985.2 1970.13 0.1015
0
10 1955 2013 1955 5 1929.26 1895.32 1853.06 5 -4 - 169

TECHNICAL ANALYSIS
12-
1808.5
May- 2054.6 2027.38 0.1209
8
10 2000.1 2064 1990 5 1942.56 1907.26 1862.29 8 57.3 + 170
13-
1811.5
May- 2099.9 0.1591
5
10 2070 2149 2056.05 2129.8 1963 1921.83 1873.37 7 72.5 +
14-
1830.1
May- 2133.7 0.1658
0
10 2130 2147 2101 2137.4 1986.49 1937.93 1886.26 9 33.8 +
17-
1852.0
May- 2159.1 2148.28 0.1599
8
10 2137.4 2174.95 2110 5 2011.9 1953.84 1898.77 3 14.6 +
18-
1892.5
May- 2157.0 2165.03
0
10 5 2271 2157.05 2173 2039.35 1969.49 1911.5 0.144 16.8 +
19-
1914.2
May- 2122.6 0.1088
0
10 2175 2175 2054 2070.2 2055.93 1980.99 1923.06 7 -42.43 - 171
20-
1918.6
May- 2099.9 2092.13 0.0904
3
10 5 2105 2031 2084.3 2068.59 1989.89 1934.11 3 -30.47 -
21-
1889.3
May- 2054.1 0.0872
3
10 2064 2095 2016.35 2044.2 2078.74 1996.66 1943.41 1 -38.03 -
24-
1908.2
May- 2134.9 2081.78 0.0909
8
10 5 2134.95 2020.1 2028.6 2089.5 2006.29 1953.76 2 27.7 + 172
25-
1894.3
May- 2009.5 2034.78 0.0741
3
10 2060 2060 1995.15 5 2095.97 2012.61 1962.2 4 -47 - 173
26-
1895.5
May- 2002.8 2040.43 0.0764
5
10 2078 2078 1992.6 5 2097.27 2019.92 1970.6 3 5.65 + 174
TECHNICAL ANALYSIS
27-
1898.7
May- 1982.2 2001.13
8
10 2020 2020 1955 5 2087.39 2025.2 1977.01 0.0539 -39.3 - 175
28-
1894.2
May- 1985.65 0.0482
3
10 1975 2035 1971.5 1996.3 2072.59 2029.54 1982.82 7 -15.47 -
31-
1890.5
May- 2105.9 2065.48 0.0925
0
10 2025 2115.5 1992 5 2064.31 2038.1 1990.66 5 79.8 + 176
1-Jun- 2088.8 1956.8 0.0592
2072.73
10 2056.6 2130 2041.15 5 2055.08 2047.21 1998.02 0 4 7.25 +
2-Jun- 2105.8 1965.5 0.0673
2097.93
10 2090 2124.95 2075.8 5 2052.61 2054.27 2004.87 0 7 25.2 +
3-Jun- 1952.6 0.0728
2094.95
10 2111 2111.95 2059 2078.9 2052.89 2060.74 2010.89 5 8 -2.975 - 177
4-Jun- 1974.1 0.0507
2074.35
10 2110 2110 2035.1 2038.7 2054.92 2066.83 2016.08 3 7 -20.6 -
7-Jun- 2028.5 1970.1 0.0322
2033.63
10 2038.7 2057 2008 5 2050.1 2069.8 2020.89 3 3 -40.72 -
8-Jun- 2020.0 2025.2 2027.3
2022.65
10 5 2085 2020.05 5 2048.89 2072.43 2024.7 8 -0.0023 -10.97 -
9-Jun- 2101.5 2099.9 0.0051
2110.78
10 2120 2128.8 2041.05 5 2055.93 2076.6 2031.92 0 8 88.1 + 178
10-Jun- 2101.8 2133.7
2110.93
10 2120 2134.9 2091.15 5 2066.91 2077.15 2039.1 0 -0.0107 0.15 +
11-Jun- 2138.9 2148.2
2107.28
10 5 2138.95 2041 2075.6 2079.07 2075.83 2046.05 8 -0.0191 -3.65 - 179
14-Jun- 2165.0
2100.85
10 2124.9 2124.9 2071.15 2076.8 2082.61 2073.46 2052.94 3 -0.0296 -6.425 -
15-Jun- 2098.8 2078.4 2122.6
2088.65
10 5 2109.95 2060 5 2084.2 2069.64 2059.54 0 -0.016 -12.2 -
16-Jun- 2092.1
2064.75
10 2050 2100 2050 2079.5 2080.88 2066.75 2063.14 3 -0.0131 -23.9 -
TECHNICAL ANALYSIS
17-Jun- 2054.1 0.0206

2096.45
10 2100 2116.9 2080 2092.9 2081.03 2066.96 2067.5 0 2 31.7 + 180
18-Jun- 2109.9 2081.7
2094.48
10 5 2120 2072.25 2079 2083.04 2068.98 2072.23 8 0.0061 -1.975 - 181
21-Jun- 2127.4 2034.7 0.0424
2121.13
10 2114.8 2136 2095.5 5 2091.79 2070.95 2077.13 8 4 26.7 + 182
22-Jun- 2040.4 0.0391
2120.35
10 2140 2171.45 2091 2100.7 2101.56 2075.23 2082.14 3 7 -0.775 - 183
23-Jun- 2119.9 2115.8 2001.1 0.0583
2117.9
10 5 2135.7 2094 5 2102.28 2079.1 2085.16 3 5 -2.45 -
24-Jun- 1985.6 0.0742
2133.1
10 2125.5 2158.8 2116.05 2140.7 2104.49 2085.7 2086.26 5 6 15.2 + 184
25-Jun- 2065.4 0.0455
2159.55
10 2150 2184.7 2150 2169.1 2109.72 2094.39 2087.13 8 5 26.5 +
28-Jun- 2072.7
2183.2
10 2181.5 2200 2180 2184.9 2117.96 2100.28 2088.29 3 0.0533 23.6 +
29-Jun- 2097.9 0.0513
2205.6
10 2200 2225 2195 2211.2 2129.65 2106.92 2089.64 3 2 22.4 +
30-Jun- 2190.7 2094.9 0.0431
2185.38
10 2180 2230 2171.55 5 2141.71 2111.3 2091.73 5 6 -20.22 - 185
1-Jul- 2205.7 2074.3 0.0589
2196.68
10 5 2213.5 2176 2187.6 2151.74 2116.38 2095.22 5 7 11.3 + 186
2-Jul- 2100.2 2162.1 2033.6 0.0479
2131.2
10 5 2215 2092 5 2155.41 2119.23 2097.79 3 8 -65.48 - 187
5-Jul- 2022.6 0.0790
2182.55
10 2201 2201 2150 2164.1 2161.55 2126.67 2101.15 5 5 51.4 + 188
6-Jul- 2195.9 2110.7 0.0263
2166.38
10 5 2195.95 2125 2136.8 2166.15 2133.86 2105.54 8 4 -16.18 - 189
7-Jul- 2110.9 0.0195
2152.1
10 2175 2175 2125 2129.2 2169.57 2135.92 2109.26 3 1 -14.28 -
8-Jul- 2135.3 2107.2 0.0239
2157.68
10 2180 2180 2130 5 2172.03 2138.26 2114.48 8 2 5.58 + 190

TECHNICAL ANALYSIS
9-Jul- 2152.1 2112.3 2100.8 0.0149

2132.25
10 5 2152.15 2104 5 2169.3 2139.51 2119.36 5 5 -25.43 - 191
12-Jul- 2088.6 0.0054
2099.95
10 2115 2131.85 2075 2084.9 2160.98 2139.47 2120.51 5 1 -32.3 -
13-Jul- 2046.4 2064.7 0.0025
2069.98
10 2093.5 2102.55 2039 5 2147.41 2138.53 2120.42 5 3 -29.97 -
14-Jul- 2081.2 2096.4
2069.78
10 2058.3 2115.9 2055.3 5 2135.85 2138.78 2119.48 5 -0.0127 -0.2 -
15-Jul- 2070.4 2094.4
2080.23
10 2090 2108 2062.3 5 2124.21 2137.97 2118.99 8 -0.0068 10.4 + 192
16-Jul- 2062.7 2121.1
2066.38
10 2070 2070 2030.1 5 2117.73 2136.57 2118.73 3 -0.0258 -13.85 - 193
19-Jul- 2120.3
2045.5
10 2041.5 2064 2041.5 2049.5 2104.02 2132.79 2119.12 5 -0.0353 -20.88 -
20-Jul- 2026.2 2117.9
2044.13
10 2062 2062 2019.05 5 2091.8 2128.97 2119.84 0 -0.0348 -1.375 -
21-Jul- 2027.8 2133.1
2027.43
10 2027 2039.95 2025 5 2079.33 2124.45 2117.06 0 -0.0495 -16.7 -
22-Jul- 2030.1 2159.5
2037.33
10 2044.5 2044.5 2005 5 2067.29 2119.66 2114.61 5 -0.0566 9.9 + 194
23-Jul- 2074.5 2183.2
2055.28
10 2036 2091.4 2033.6 5 2059.6 2114.45 2112.87 0 -0.0586 18 +
26-Jul- 2205.6
2080.85
10 2099 2110 2054.05 2062.7 2057.69 2109.33 2112.21 0 -0.0566 25.6 +
27-Jul- 2056.8 2185.3
2063.93
10 2071 2084.95 2051.05 5 2057.08 2102.25 2111.38 8 -0.0556 -16.92 - 195
28-Jul- 2196.6
2066.95
10 2066.5 2104.55 2060.5 2067.4 2056.8 2096.33 2111.45 8 -0.0591 3.02 + 196
29-Jul- 2131.2
2047.45
10 2070 2070 2020.2 2024.9 2053.52 2088.86 2109.82 0 -0.0393 -19.5 - 197
29-Jul- 2182.5
2047.45
10 2070 2070 2020.2 2024.9 2051.63 2084.68 2108.25 5 -0.0619 0

TECHNICAL ANALYSIS
30-Jul- 2166.3
2027
10 2038.2 2038.2 2000 2015.8 2049.78 2076.9 2105.12 8 -0.0643 -20.45 - 198
3-Aug- 2152.1
2017.65
10 2030.4 2030.4 2001.25 2004.9 2047.13 2069.46 2101.69 0 -0.0625 -9.35 -
4-Aug- 2157.6
2005
10 2010 2035 1984 2000 2044.89 2062.11 2097.93 8 -0.0708 -12.65 -
5-Aug- 2132.2
2015.95
10 2020 2030 1995 2011.9 2042.75 2055.02 2094.02 5 -0.0545 11 + 199
6-Aug- 2099.9
2018.5
10 2019.9 2028.7 2010 2017.1 2039.07 2049.33 2089.32 5 -0.0388 2.55 +
9-Aug- 1997.4 2069.9
2008.73
10 2020 2058 1990 5 2031.86 2044.77 2083.51 8 -0.0296 -9.775 - 200
10- 1990.7 2069.7
2000.38
Aug-10 2010 2035 1980 5 2025.51 2041.29 2076.67 8 -0.0335 -8.35 -
11- 1958.3 2080.2
1995.18
Aug-10 2032 2032 1949 5 2018.33 2037.56 2070.33 3 -0.0409 -5.2 -
12- 1957.0 1953.5 2066.3
1955.3
Aug-10 5 1965 1942 5 2009.11 2031.32 2062.28 8 -0.0538 -39.88 -
13- 1960.9 2045.5
1955.98
Aug-10 1951 1985 1942 5 1999.97 2025.8 2056.44 0 -0.0438 0.67 + 201
16- 2044.1
1958.6
Aug-10 1971.2 1988 1941 1946 1993.13 2021.45 2048.97 3 -0.0418 2.63 +
17- 1961.7 2027.4
1955.88
Aug-10 1950 1968.9 1942.05 5 1986.95 2017.04 2041.96 3 -0.0353 -2.725 - 202
18- 2037.3
1948.7
Aug-10 1953 1969.5 1940 1944.4 1981.32 2013.1 2035.18 3 -0.0435 -7.175 -
19- 1980.7 2055.2
1961.88
Aug-10 1943 1988.8 1935 5 1975.91 2009.33 2028.65 8 -0.0454 13.2 + 203
20- 2080.8
2002.95
Aug-10 1990 2040 1981.05 2015.9 1974.36 2006.71 2024.34 5 -0.0374 41.1 +
23- 2063.9
2007.35
Aug-10 2039 2040.95 1966 1975.7 1974.22 2003.04 2021.25 3 -0.0274 4.4 +

TECHNICAL ANALYSIS
24- 1946.4 2066.9

1960.73
Aug-10 1975 2015 1940 5 1970.25 1997.88 2017.61 5 -0.0514 -46.63 - 204
25- 1944.9 1883.1 2047.4
1914.05
Aug-10 5 1945 1880 5 1962.14 1990.23 2012.42 5 -0.0652 -46.67 -
26- 2047.4
1880.95
Aug-10 1890 1895 1852 1871.9 1954.71 1981.91 2005.78 5 -0.0813 -33.1 -
27- 2027.0
1874.7
Aug-10 1880 1912 1860 1869.4 1946.58 1973.27 1999.39 0 -0.0751 -6.25 -
30- 2017.6
1890.3
Aug-10 1890 1907.9 1885.15 1890.6 1939.75 1966.44 1994.22 5 -0.0631 15.6 + 205
31- 2005.0
1879.55
Aug-10 1897.9 1899 1850 1861.2 1932.12 1959.53 1988.73 0 -0.0626 -10.75 - 206
1-Sep- 1899.6 1879.4 2015.9
1889.55
10 5 1899.65 1876.05 5 1926.2 1953.76 1984.14 5 -0.0627 10 + 207
2-Sep- 2018.5
1897.35
10 1885 1935 1880 1909.7 1919.75 1947.83 1979.47 0 -0.06 7.8 +
3-Sep- 1917.8 2008.7
1921.43
10 1925 1930 1912 5 1911.6 1942.98 1975.01 3 -0.0435 24.1 +
6-Sep- 1917.6 2000.3
1928.33
10 1939 1939 1916.5 5 1903.69 1938.96 1969.92 8 -0.036 6.9 +
7-Sep- 1995.1
1916.6
10 1916.5 1928.95 1916 1916.7 1899.28 1934.77 1965.01 8 -0.0394 -11.73 - 208
8-Sep- 1917.4 1955.3
1908.73
10 1900 1922.95 1900 5 1898.75 1930.44 1959.74 0 -0.0238 -7.875 -
9-Sep- 1916.6 1955.9
1915.83
10 1915 1924.9 1906.6 5 1902.24 1928.47 1955.35 8 -0.0205 7.1 + 209
24- 2110.9 1958.6 0.0622
2080.48
Sep-10 2050 2134 2050 5 1922.81 1934.7 1956.45 0 3 165 +
27- 2144.2 1955.8 0.0952
2142.13
Sep-10 2140 2157.9 2091.5 5 1948 1943.87 1960.29 8 3 61.7 +
28- 2153.3 1948.7 0.1041
2151.68
Sep-10 2150 2171 2130.25 5 1975.21 1953.66 1964.76 0 6 9.55 +

TECHNICAL ANALYSIS
29- 1961.8 0.1231

2203.45
Sep-10 2163 2251 2163 2243.9 2006.6 1966.4 1971.37 8 3 51.8 +
30- 2002.9 0.1107
2224.85
Sep-10 2240 2284.9 2199.5 2209.7 2039.35 1979.55 1978.34 5 9 21.4 +
Total 4328 -3285
4327.7
∑G 3
3284.8
∑L 0
No. of Gain 251
No.of Lose 219
Daily Average gain 17.24

Daily Average lose 15.00
Relative strength 1.15
Relative strength of
index 53.48

TECHNICAL ANALYSIS
MOVING AVERAGE
An indicator frequently used in technical analysis showing the average value of a security's price over a set period. Moving averages are generally
used to measure momentum and define areas of possible support and resistance.
In this, I have calculate three moving average on the bases of 10 days , 20days and 30 days.
Moving average charts is a tool used by technical analysts to track the price movements of a security. It plots average daily settlement prices over
a defined period of time like 10 days, 20 days, and 30 days.
INTERPETATION

TECHNICAL ANALYSIS
As per tree different period moving average charts show the trend of GSK in BSE.10 days and less than 10 days moving average is helpful
for short term investment .For long term investors 30 days moving average and more than 30 days moving average is helpful for investment in
stock market.
Here GSK market performance was good and its moving average trend is in increasing form. Moving averages can be used to quickly
identify whether a security is moving in an uptrend or a downtrend depending on the direction of the moving average. As charts when a moving
average is heading upward and the price is above it, the security is in an uptrend. Conversely, a downward sloping moving average with the price
below can be used to signal a downtrend.
RELATIONSHIP BETWEEN SHARE PRICE AND MOVING AVERAGE
INTERPETATION
As shown in the above chart, the market price is below the moving average line also both the market price and moving average is moving along
the line, also it has reached the resistance level, hence it is advisable to long term investors to sell the share and book the profit at the same time it
advisable to the short term investors to buy the share and hold it for mere future and sell it when it reaches the support level. Thus it is good sign
to sell to long term investors
OSCELLATOR
Oscellator is a technical analysis tool that is banded between two extreme values and built with the results from a trend indicator for discovering
short-term overbought or oversold conditions. As the value of the oscillator approaches the upper extreme value the asset is deemed to be
overbought, and as it approaches the lower extreme it is deemed to be oversold.
TECHNICAL ANALYSIS
INTERPETATION
OVER BOUGHT
According to GSK oscillator chart, company oscillator value 1.9583 on 25 Nov 2008. This is the highest value of last two years, this is the
position of over brought so, this is the moment where investors should sell their investmentment, and move towards another investvestment where
there is a great prospect of profitability. When we move further and a glance of data from1dec 08 to 30sep10 the maximum achievable value is
on 25 nov 2008. But when we move towards minimum level the maximum oversold position is on 3 nov 2008 i.e. -0.1241 that is the position
where an investor should invest in the particular stock or if an exist investor then shoud hold the stock till it reaches it maximum level.
If we talk about 30 sep 2010 then we get the value near than over brought so, it is a the time where investor should sold the stock, and for new
investor that not to purchase the particular stock in the mean time. Because, when the market correction will done the value of stock definitely
decreases.
OVER SOLD
HEAD AND SHOULDERS
A head and shoulders pattern is also a trend reversal formation. It is formed by a peak (shoulder), followed by a higher peak (head), and then
another lower peak (shoulder). A "neckline" is drawn by connecting the lowest points of the two troughs. The slope of this line can either be up or
down. Typically, when the slope is down, it produces a more reliable signal.

TECHNICAL ANALYSIS
Interpretation:-
When we show the head and shoulder chart we find an uneven trend of stock movement, because there is number of head and shoulders drawn
over a period of time, and if we talk about movement of stock of last two years there is a increasing trend follow by the stock, as we learn earlier
that a upward stock movement is not so reliable due to this the current scenario is not the positive for the investment. Because, from 1st oct 08 to
30th sep 10 the head and shoulder movement is purely upward so, there is not a good time to investment as this point at 30th sep of near about 2200
so, it is the situation where investor should sale its investment and not the purchase of the same stock.
CANDLE STICK CHARTS

Candlestick is formed with the help of opening, high, low and closing price of the day. If the opening price is above the closing price then a filled
candlestick is drawn. Normally, black colour is used for filling the candle. If the closing price is above the opening price, then a hollow
candlestick (normally displayed in white with black border) is drawn. The filled or the hollow portion of the candle is known as body or real body
which can belong, normal or short with proportionate to the line above or below it. The lines (long or short) above and below the body or real

TECHNICAL ANALYSIS
body represent the high or low price range and these lines are known as shadows, tails or wicks. For the particular day, the highest price is
declared by the top of the upper shadow and the lowest price is marked by the bottom of the lower tail.
Interpretation:-The candlestick chart shows the daily price movement of a stock by four ways i.e. Open, High, Low, Close. So, we get a actual
figure of a stock whether the stock is over sold or over brought in the particular day, and also give a brief of the behavior of sort sellers or
speculators in the intraday and interday transactions. When we talk about the candlestick diagram of last two years we find that over low high and
close is increasing over a period of last two years so, it shows the growth from company’s prospect but it is not good from new investor’s purpose.
As, it is good for long term investors but vice-versa for short term investor purpose.
V-FORMATION
RESISTANCE & SUPPORT LEVEL

TECHNICAL ANALYSIS
Support and resistance is a concept in technical analysis that the movement of the price of a security will tend to stop and reverse at certain predetermined
price levels.
A support level is a price level where the price tends to find support as it is going down. This means the price is more likely to "bounce" off this
level rather than break through it. However, once the price has passed this level, by an amount exceeding some noise, it is likely to continue
dropping until it finds another support level.
A resistance level is the opposite of a support level. It is where the price tends to find resistance as it is going up. This means the price is more
likely to "bounce" off this level rather than break through it. However, once the price has passed this level, by an amount exceeding some noise, it
is likely that it will continue rising until it finds another resistance level.
Interpretation:-
If we talk about support and resistance level of GSK of last two years we find that 1250 and 1800. As, we show the stock of gsk cross the support
level at 1st july09 and cross the resistance level 10th Apr10. And from that movement the stock is continuously moving on and on. So, till 10th apr
there was a good investment prospect. But after 10th apr 10 when stock cross the resistance level it shows the investment in the particular stock is
made some sort of risky investment so it is good stock for long term investor and not for short term investor as the last price of stock at 30th sep 10
is 2210 so, it is highly risky stock for new investors and suggestion is not to invest in this particular stock in the mean time.
Conclusion:-

TECHNICAL ANALYSIS
The study is concerned with the relevant features of technical analysis and about its indicators. Technical analysis is widely accepted
worldwide and a very useful tools for the analysis of share price behavior. The share market is more challenging, fulfilling and rewarding to
resourceful investors willing to learn the art of cyclical timing to study of technical analysis.
The technical approach to invest is essentially a reflection of the idea that price moves in trends which are determined by the challenging
attitudes of investors towards a variety of economic, monetary, political and psychological forces. By studying the nature of previous market
turning points it is possible to develop some characteristics that can help to identify major markets top and bottoms. The recognition of top and
bottoms is in nutshell of technical analysis process. Entering the market at the beginning of the up-trend and getting out of it at the first stroke of
the formation in the reversal is the basis of this analysis.
As we do the technical analysis of gsk pharma we find some outcomes i.e. under here-
• Company is having a good growth rate.

• The investor should choose the particular stock wisely.
• The stock is good for long term investors.
• In the current time there is a good time to sell the particular stock and should purchase the new with same fetures.
• The stock is highly volatile stock as it is a front line stock.
• In the mean time stock is good for speculators if, they are able to take risks.
• The stock is not good for the new investors as correction is required, and stock is also overbought.
• The stock is showing its Bullish trend over a period of time.
• There is a positive correlation in between the stock and market (BSE) price.

TECHNICAL ANALYSIS
Bibliography:-
Websites:
• www.forextrading.about.com
• www.investopedia.com
• www.about.com
• www.sify.com/finance
• www.bse.com
• www.capitaline.com
•
Books Referred
• Technical Analysis of the Financial Markets By John J. Murphy

• Investment analysis and portfolio management By Prasanna Chandra.

Technical Analysis of GSK PHARMA.

Uploaded by

Document Information

Original Description:

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Technical Analysis of GSK PHARMA.

Uploaded by

Copyright:

Available Formats

TECHNICAL ANALYSIS

TECHNICAL ANALYSIS OF GLAXOSMITHKLINE PHARMA

Submitted To: Mr. Amarjit Saini Submitted By:

LOVELY PROFESSIONAL UNIVERSITY Page 2

LOVELY PROFESSIONAL UNIVERSITY Page 3

• Over-the-counter (OTC) medicines including Gaviscon and Panadol

LOVELY PROFESSIONAL UNIVERSITY Page 4

LOVELY PROFESSIONAL UNIVERSITY Page 5

GSK’S WORLDWIDE MAP

LOVELY PROFESSIONAL UNIVERSITY Page 6

United Kingdom Cyprus Iceland Netherlands Spain

Austria Denmark Italy Poland Switzerland

Argentina Costa Rica Honduras Uruguay

Algeria Morocco South Africa Kenya Nigeria

INTRODUCTION OF THE COMPANY IN INDIA

The GSK India product portfolio includes:-

LOVELY PROFESSIONAL UNIVERSITY Page 9

LOVELY PROFESSIONAL UNIVERSITY Page 10

HISTORY 0F THE COMPANY

The Well come Tropical Research Laboratories open

Production of Beecham's Pills laxative reaches one million a day.

Glaxo acquires Allen and Hanburys Ltd.

LOVELY PROFESSIONAL UNIVERSITY Page 13

DEVELOPMENT OF THE COMPANY

LOVELY PROFESSIONAL UNIVERSITY Page 14

• Most family friendly company

PRODUCTS OF THE COMPANY

LOVELY PROFESSIONAL UNIVERSITY Page 16

LOVELY PROFESSIONAL UNIVERSITY Page 17

LOVELY PROFESSIONAL UNIVERSITY Page 18

NAME OF BOARD OF DIRECTORS

Andrew Witty - Chief Executive Officer

Professor Sir Roy Anderson - Non-Executive Director

Dr Stephanie Burns - Non-Executive Director

Lawrence Culp - Non-Executive Director

Sir Crispin Davis - Non-Executive Director

Julian Heslop - Chief Financial Officer

Sir Deryck Maughan - Non-Executive Director

Dr Daniel Podolsky - Non-Executive Director

Sir Ian Prosser - Senior Independent Non-Executive Director

Dr Ronaldo Schmitz - Non-Executive Director

Moncef Slaoui - Chairman, Research & Development

Tom de Swaan - Non-Executive Director

Chris Viehbacher - President, North American Pharmaceuticals

Sir Robert Wilson - Non-Executive Director

CORPORATE EXECUTIVE TEAM

Andrew Witty - Chief Executive Officer

John Clarke - President, Consumer Healthcare

Marc Dunoyer - President, Asia Pacific/Japan

Eddie Gray - President, Pharmaceuticals Europe

Julian Heslop - Chief Financial Officer

Abbas Hussain - President, Emerging Markets

Bill Louv - Chief Information Officer

Dan Phelan - Chief of Staff

LOVELY PROFESSIONAL UNIVERSITY Page 20

David Pulman - President, Global Manufacturing and Supply

David Redfern - Chief Strategy Officer

Moncef Slaoui - Chairman, Research & Development

Jean Stéphenne - President and General Manager, Biological

Claire Thomas - Senior Vice President, Human Resources

Chris Viehbacher - President, North American Pharmaceuticals

Bob Ingram - Vice Chairman, Pharmaceuticals